nifedipine has been researched along with Heart Failure in 222 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Long-term therapy with aerosolized iloprost (long-acting PGI(2) analog) resulted in unequivocal clinical improvement from a state of immobilization and severe resting dyspnea in a patient with decompensated right heart failure." | 9.09 | Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. ( Ghofrani, HA; Grimminger, F; Olschewski, H; Schermuly, R; Seeger, W; Temmesfeld-Wollbruck, B; Walmrath, D, 1999) |
| "We performed a prospective, randomized, double-blind, crossover study to compare the efficacy and safety of vasodilation with the calcium entry blocker nifedipine with that of isosorbide dinitrate (ISDN) and their combination as treatment for heart failure." | 9.06 | A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. ( Amin, J; Elkayam, U; Mehra, A; Rahimtoola, SH; Vasquez, J; Weber, L, 1990) |
| "18 patients with II NYHA class chronic congestive heart failure (CCHF) had been given nifedipine (Cordipin) 54." | 9.06 | [Evaluation of the effect of nifedipine in patients with chronic congestive heart failure]. ( Bechler-Lisińska, J; Broks-Bratkowska, B; Cholewa, M; Dryjański, T; Gawor, Z; Górski, L; Markiewicz, K, 1989) |
| "We evaluated the effects of intravenous hydralazine (5 to 30 mg) and oral nifedipine (20 to 80 mg) on plasma catecholamines, renin, and aldosterone in 18 patients with severe chronic heart failure." | 9.06 | Neurohumoral consequences of vasodilator therapy with hydralazine and nifedipine in severe congestive heart failure. ( Elkayam, U; Freidenberger, L; Hsueh, W; Rahimtoola, SH; Roth, A; Weber, L, 1986) |
| "Afterload reduction with angiotensin-converting enzyme inhibitors (ACE-inhibitors), such as captopril, is an established therapeutic measure in the adjunctive treatment of severe chronic heart failure." | 9.06 | [Clinical and hemodynamic effects of nisoldipine and captopril in heart failure: a double-blind comparative study of long and short-term effects]. ( Figulla, HR; Kreuzer, H; Luig, H; Nieschlag, F, 1987) |
| " In order to evaluate the relationship between the mode of action of nitrates at cellular level and their vasodilatory effectiveness, we studied the circulatory response of the forearm to isosorbide dinitrate and the influence of nitroglycerin on free calcium concentration in the platelets in 10 patients with chronic heart failure." | 8.78 | Relationship between the inhibition of receptor-induced increase in cytosolic free calcium concentration and the vasodilator effects of nitrates in patients with congestive heart failure. ( Baldenkov, GN; Mazaev, AV; Mukharliamov, NM; Negrescu, EV; Sazonova, LN; Tkachuk, VA, 1990) |
| "This study was designed to examine the hypothesis that a calcium channel blocker nifedipine (CCB) could enhance the cardioprotective effect of an angiotensin-ll receptor blocker candesartan (ARB) in the treatment for heart failure." | 7.73 | Nifedipine enhances the cardioprotective effect of an angiotensin-II receptor blocker in an experimental animal model of heart failure. ( Hayashi, T; Horimoto, H; Inamoto, S; Kitaura, Y; Mieno, S; Mori, T; Okabe, M; Okuda, N, 2005) |
| "Past studies have suggested that amlodipine, a dihydropyridine L-type Ca(2+) channel antagonist, may exert useful effects in congestive heart failure (CHF)." | 7.71 | Comparison of amlodipine or nifedipine treatment with developing congestive heart failure: effects on myocyte contractility. ( Clair, MJ; Gay, DM; Goldberg, A; Hendrick, JW; Jolly, JR; King, MK; McElmurray, JH; Mukherjee, R; Patterson, TM; Spinale, FG, 2001) |
| "The effect of nifedipine on ventriculoarterial coupling was examined in 8 patients with old myocardial infarction who showed a depressed ejection fraction (37 +/- 7%)." | 7.69 | The effect of nifedipine on ventriculoarterial coupling in old myocardial infarction. ( Fujii, T; Hiro, T; Katayama, K; Kohno, M; Matsuzaki, M; Miura, T; Seki, K; Yano, M, 1996) |
| "The impact of intravenous infusion of nifedipine and nitroglycerin on invasive central hemodynamic parameters and microcirculation was compared in 94 patients with acute myocardial infarction complicated by heart failure." | 7.68 | [Heart failure in acute myocardial infarction: comparing infusions of nifedipine and nitroglycerin]. ( Gruzdev, AK; Kosminskiĭ, PG; Lazarev, IA; Magnitskiĭ, AV; Sidorenko, BA; Vaniev, SB; Vasechkin, SS, 1992) |
| "The acute hemodynamic effects of nilvadipine, a newly synthesized calcium channel blocker, were studied in 12 patients with congestive heart failure." | 7.68 | Acute hemodynamic effects of nilvadipine, a new calcium channel blocker, in patients with congestive heart failure. ( Aoyagi, T; Iizuka, M; Ikenouchi, H; Matsui, H; Mochizuki, T; Momomura, S; Sato, H; Serizawa, T; Sugimoto, T, 1990) |
| "Haemodynamic effects of nifedipine (NIF) tablets were studied for 12 h in 10 patients with severe congestive heart failure due to ischaemic heart disease." | 7.68 | Haemodynamic effects of slow-release nifedipine in severe congestive heart failure due to ischaemic heart disease. ( Rossi, A; Ziacchi, V, 1990) |
| "In 22 of 27 cases of congestive heart failure (CHF) treated with nifedipine (NIF), significant improvements in resting hemodynamics were noticed." | 7.68 | Nifedipine pharmacodynamics and pharmacokinetics in treatment of congestive heart failure. ( Chen, DG; Chen, K; Feng, QP; Wang, ZQ, 1990) |
| "To elucidate the hemodynamic responses to sublingual nifedipine administration during exercise and recovery in congestive heart failure, 16 patients with dilated cardiomyopathy (DCM) and 11 controls were studied using supine bicycle exercise testing." | 7.68 | [Hemodynamic responses to sublingual nifedipine during exercise and recovery in congestive heart failure]. ( Amioka, H; Hashimoto, M; Kajiyama, G; Kawagoe, T; Matsuura, H; Morichika, N; Nakagawa, H; Okamoto, M; Tsuchioka, Y; Yamagata, T, 1990) |
| "Clinical, hemodynamic and neurohumoral data are available supporting the validity of a differentiated approach to administration of combined treatment with furosemide, digoxin and calcium antagonists nifedipine and verapamil in advanced-aged patients with hypertension complicated by circulatory disorders." | 7.68 | [Evaluation of the effectiveness of calcium antagonists combined with digoxin and furosemide in hypertension complicated by circulatory insufficiency in elderly patients]. ( Orynchak, MA, 1990) |
| "The effect of 2-month treatment with isosorbide dinitrate (120 mg day-1), nifedipine (2 x 20 mg day-1) and their combination has been assessed in 16 patients with mild to moderate chronic cardiac failure." | 7.68 | Long-term effect of isosorbide dinitrate and nifedipine, singly and in association, in patients with chronic heart failure. ( Feuereisl, R; Jezek, V; Jezková, J; Michaljanic, A; Niederle, P, 1990) |
| "The acute hemodynamic response to a single oral dose of nitrendipine (10-20 mg) was evaluated in eight subjects with severe chronic congestive heart failure during right heart catheterization." | 7.67 | Acute hemodynamic effects of nitrendipine in chronic congestive heart failure. ( Cohn, JN; Levine, TB; Olivari, MT, 1984) |
| "The acute effect of nifedipine (Adalat, Bayer) was evaluated in 54 men with a history of transmural myocardial infarction." | 7.67 | Evaluation of the effect of nifedipine in men after myocardial infarction. ( Jedlicka, J; Kidéry, J; Málek, I; Nestával, A; Oppelt, A; Stanĕk, V, 1984) |
| "The central and renal hemodynamic effects of nifedipine were evaluated in nine patients with severe chronic congestive heart failure." | 7.67 | Renal hemodynamic effects of vasodilation with nifedipine and hydralazine in patients with heart failure. ( Campese, VM; Elkayam, U; Massry, SG; Rahimtoola, SH; Weber, L, 1984) |
| "Ten patients with moderate to severe congestive heart failure (CHF) underwent central and regional hemodynamic measurements at rest and central hemodynamic measurements during exercise before and after the oral administration of nifedipine (0." | 7.67 | Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow. ( Hermiller, J; Huss, P; Leier, CV; Magorien, RD; Pacht, KD; Patrick, TJ; Unverferth, DV, 1984) |
| "The effects of intravenous nicardipine (10 mg) on some aspects of left ventricular function have been studied with a radioisotope method in 10 male patients in chronic heart failure (NYHA Class II and III)." | 7.67 | Intravenous nicardipine in patients with chronic heart failure: a nuclear stethoscope study. ( Caruana, MP; Harlow, BJ; Kohli, RS; Lahiri, A; Raftery, EB; Robinson, CW; Tovey, J, 1984) |
| "The use of nifedipine in patients with hypertension, heart failure, and acute myocardial infarction is discussed." | 7.67 | Nifedipine in hypertension and heart failure. ( Matsui, S; Murakami, E; Murakami, H; Takekoshi, N, 1984) |
| " Therefore, intravenous diltiazem (100 to 200 micrograms/kg per min infusion) was administered for 40 minutes followed by oral diltiazem (90 to 120 mg/8 hours) for 24 hours to patients with advanced congestive heart failure (New York Heart Association class III to IV, mean ejection fraction 26 +/- 4 [SD])." | 7.67 | Beneficial hemodynamic effects of intravenous and oral diltiazem in severe congestive heart failure. ( O'Rourke, RA; Porter, CB; Starling, MR; Walsh, RW, 1984) |
| "The hemodynamic effects of 20 to 40 mg of oral nifedipine were compared with those of intravenous nitroprusside in 11 patients with severe chronic congestive heart failure (CHF)." | 7.67 | Comparison of hemodynamic responses to nifedipine and nitroprusside in severe chronic congestive heart failure. ( Elkayam, U; McKay, CR; Rahimtoola, SH; Torkan, B; Weber, L, 1984) |
| "The hemodynamic response to a similar reduction of systemic vascular resistance after nifedipine and hydralazine administration was compared in a randomized crossover protocol in patients with severe chronic congestive heart failure (CHF)." | 7.67 | Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure. ( Elkayam, U; McKay, CR; Rahimtoola, SH; Weber, L, 1984) |
| " The combination of nitrendipine plus enalapril was also examined in ischemic failure and in rats with spontaneous hypertension." | 7.67 | Enalapril in experimental hypertension and acute heart failure: comparison with calcium channel blockers. ( Adkins, E; Emmert, S; Ludden, CT; Ribeiro, LG; Seymour, AA; Sweet, CS, 1986) |
| "The haemodynamic effects of nifedipine (20 mg sublingually) were studied in 40 patients with acute myocardial infarction within 18 h of the onset of symptoms." | 7.67 | Nifedipine following acute myocardial infarction--dependence of response on baseline haemodynamic status. ( Jackson, NC; Nelson, GI; Reynolds, GW; Silke, B; Taylor, SH; Verma, SP; Wilson, JA, 1987) |
| "The acute hemodynamic effects of intravenous nisoldipine were studied in 10 patients with severe congestive heart failure." | 7.67 | Intravenous nisoldipine in severe congestive heart failure. ( Armstrong, PW; Frankel, D; Karlinsky, SJ; Moe, GW, 1988) |
| "Twenty-seven cases of congestive heart failure (CHF) were treated with nifedipine (Nif) 20 mg po." | 7.67 | [Pharmacodynamics and pharmacokinetics of nifedipine in patients with congestive heart failure]. ( Chen, DG; Chen, K; Feng, QP; Wang, ZQ, 1989) |
| "Nisoldipine, a calcium entry blocker, was given to 10 patients with congestive heart failure." | 7.67 | Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure. ( Barjon, JN; Bichet, D; De Champlain, J; Juneau, C; Rouleau, JL, 1987) |
| "Nitroglycerin and nifedipine have been suggested as useful agents in the therapy of congestive heart failure." | 7.67 | A comparative evaluation of hemodynamic and neurohumoral effects of nitroglycerin and nifedipine in congestive heart failure. ( Armstrong, PW; Lefkowitz, CA; Moe, GW, 1987) |
| "Nifedipine was used successfully in nine patients with refractory hypertension and left ventricular hypertrophy who had symptoms of congestive heart failure despite preserved left ventricular systolic function." | 7.67 | Nifedipine in severely hypertensive patients with congestive heart failure and preserved ventricular systolic function. ( Dzau, VJ; Given, BD; Lee, TH; Stone, PH, 1985) |
| "A patient with congestive heart failure and normal renal function developed anuria during treatment with nifedipine." | 7.67 | Acute renal failure during nifedipine therapy in a patient with congestive heart failure. ( Chalopin, JM; Eicher, JC; Louis, P; Morelon, P; Rifle, G; Tanter, Y, 1988) |
| "Twelve patients referred for evaluation of functional class 4 heart failure as classified by the New York Heart Association underwent treatment with nifedipine after other regimens proved unsatisfactory." | 7.67 | Improvement in NYHA functional class 4 congestive heart failure patients with nifedipine: a hemodynamic evaluation. ( Olson, L; Vlay, SC, 1988) |
| "We studied the acute effects of nisoldipine, a new second-generation calcium channel-blocking drug, on cardiac hemodynamics and left ventricular (LV) contractility in 10 patients with grade 2 to 4 cardiac failure." | 7.67 | Effect of the second-generation calcium channel blocker nisoldipine on left ventricular contractility in cardiac failure. ( Flugelman, MY; Halon, DA; Hardoff, R; Lewis, BS; Merdler, A; Shefer, A, 1988) |
| "The systemic and coronary hemodynamic and neurohumoral effects of nisoldipine, a calcium antagonist drug with high vascular specificity, were investigated in 17 patients with chronic congestive heart failure (CHF)." | 7.67 | Arterial vasodilator, systemic and coronary hemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathy. ( Buehler, FR; Burkart, F; Erne, P; Kiowski, W; Mueller, J; Pfisterer, M, 1987) |
| "The hemodynamic effects of increasing oral doses of nifedipine (10 to 30 mg) were studied in 12 patients who had low output heart failure." | 7.67 | Characterization of the dose-concentration-dependent hemodynamic effects of nifedipine in heart failure. ( Gengo, FM; Green, JA; Nara, AR, 1987) |
| "The hemodynamic response to vasodilation induced by the new calcium channel antagonist nicardipine was studied in 10 patients with severe, chronic congestive heart failure." | 7.67 | Effect of nicardipine on rest and exercise hemodynamics in chronic congestive heart failure. ( Cody, RJ; Kubo, SH; Lystash, J; Ryman, KS; Stone, G, 1986) |
| "To determine if the addition of preload reduction with nitrates would potentiate the acute vasodilator actions of nifedipine, we titered intravenous nitroglycerin in seven patients with severe congestive heart failure after they received a single oral dose of nifedipine." | 7.67 | Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure. ( Cody, RJ; Fox, SC; Kubo, SH; Prida, XE, 1985) |
| "To evaluate the short-term hemodynamic and neuroendocrine effects of nifedipine in heart failure, it was compared with nitroprusside, a balanced vasodilator without known inotropic effect, in equihypotensive doses during right and left heart catheterization in nine patients with heart failure." | 7.67 | Inotropic, vascular and neuroendocrine effects of nifedipine in heart failure: comparison with nitroprusside. ( Barry, WH; Colucci, WS; Fifer, MA; Jaski, BE; Lorell, BH, 1985) |
| "Nine patients with chronic, severe (New York Heart Association class III to IV) congestive heart failure were studied to determine the acute effects of 10 mg of sublingual nifedipine on left ventricular (LV) function." | 7.67 | Sublingual nifedipine: acute effects in severe chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy. ( Bass, TA; Conetta, DA; Miller, AB, 1985) |
| "The acute hemodynamic effects of 20 to 50 mg of orally administered nifedipine were evaluated in 31 patients with severe chronic congestive heart failure (CHF) and the results were analyzed according to the response of the cardiac index (CI)." | 7.67 | Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure. ( Elkayam, U; McKay, C; Rahimtoola, S; Weber, L, 1985) |
| "The effects of oral nifedipine on limb hemodynamics were studied in 7 normal subjects, 8 patients with congestive heart failure and 2 patients who underwent sympathectomy of unilateral limb." | 7.67 | Effects of nifedipine on forearm vascular resistance and venous capacitance in normal subjects and in patients with congestive heart failure. ( Hattori, N; Ikeda, T; Kitamura, T; Nakamura, Y; Takata, S; Yamamoto, M, 1985) |
| " Two cases and a review of the literature relating to treatment of hypertensive emergencies with nifedipine are presented." | 7.67 | Nifedipine in the management of hypertensive emergencies: report of two cases and review of the literature. ( Checcio, LM; Cohan, JA, 1985) |
| "The temporal hemodynamic effects of oral nifedipine after a single dose of 20 to 40 mg were evaluated in 11 patients with severe chronic congestive heart failure (left ventricular ejection fraction 0." | 7.66 | Acute hemodynamic effect of oral nifedipine in severe chronic congestive heart failure. ( Berman, D; Elkayam, U; Rahimtoola, SH; Torkan, B; Weber, L, 1983) |
| "The acute haemodynamic effects of nifedipine (10 mg sublingually) and isosorbide dinitrate (5 mg sublingually) were compared in 13 patients with heart failure due to acute myocardial infarction." | 7.66 | Comparison of acute haemodynamic effects of nifedipine and isosorbide dinitrate in patients with heart failure following acute myocardial infarction. ( Bracchetti, D; Cantelli, I; Naccarella, F; Pavesi, PC, 1981) |
| "Nifedipine, a potent coronary vasodilator, was administered in a single sublingual dose of 20 mg to eight patients with mild to moderate congestive heart failure." | 7.66 | Hemodynamic effects of nifedipine in congestive heart failure. ( Ito, T; Ito, Y; Matsumoto, S; Okabe, F; Sada, T; Sato, M; Sekine, I; Su, KM; Takahashi, M; Ueda, A, 1980) |
| "Hemodynamic response of nifedipine in 11 patients with congestive heart failure was examined." | 7.66 | Hemodynamic effects of sublingual nifedipine in congestive heart failure. ( Fujita, S; Hiramaru, Y; Kitano, E; Masuya, K; Matsui, S; Murakami, E; Murakami, H; Nomura, M; Saga, T; Takekoshi, N; Tsuji, S, 1979) |
| "Nifedipine was administered in a dose of 30 mg orally to 14 patients with coronary heart disease and clinical evidence of left heart failure." | 7.66 | [The effect of nifedipine on the pulmonary artery pressure in patients with coronary heart disease (author's transl)]. ( Beck, OA; Hochrein, H, 1978) |
| " We conclude that the long-term administration of nilvadipine (16 mg daily) is neither effective nor harmful in the treatment of patients with chronic heart failure." | 6.67 | Long-term clinical effect of nilvadipine in patients with chronic heart failure: a double-blind placebo-controlled study. ( Hayashi, T; Hoki, N; Hori, M; Kamada, T; Karita, M; Kodama, K; Naka, M; Nanto, S; Sato, H; Yamada, Y, 1994) |
| "Calcium antagonists are used in the treatment of hypertension and angina." | 6.44 | The ACTION study: nifedipine in patients with symptomatic stable angina and hypertension. ( Coca, A; Sierra, C, 2008) |
| "Myocyte apoptosis and muscle atrophy were significantly decreased with irbesartan compared with untreated CHF rats." | 5.31 | Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure. ( Angelini, A; Battista Ambrosio, G; Dalla Libera, L; Ravara, B; Rossini, K; Sandri, M; Thiene, G; Vescovo, G, 2001) |
| "Nisoldipine produced an increase in LV filling fraction from 36 +/- 17% to 43 +/- 20% (p = 0." | 5.28 | Effect of the second-generation calcium channel blocking drug nisoldipine on diastolic left ventricular dysfunction in heart failure. ( Flugelman, MY; Halon, DA; Hardoff, R; Lewis, BS; Merdler, A; Shefer, A, 1989) |
| "were studied in 15 patients with chronic congestive heart failure due to ischemic heart disease or cardiomyopathy." | 5.27 | Hemodynamic effects of nisoldipine in chronic congestive heart failure. ( Kreuzer, H; Vogt, A, 1983) |
| "Felodipine is a new calcium antagonist with a high degree of vascular selectivity." | 5.27 | Acute haemodynamic and metabolic effects of felodipine in congestive heart failure. ( Campbell, S; Jewitt, DE; Monaghan, MJ; Timmis, AD; Walker, L, 1984) |
| "Nifedipine is an effective agent for the treatment of postinfarction heart failure accompanied with high peripheral resistance." | 5.27 | [Use of nifedipine for treating heart failure in the subacute period of myocardial infarct in patients over 60]. ( Chistova, VS; Glezer, MG; Iakovlev, SV; Lazutin, VK; Sergeeva, EV, 1987) |
| "Nicardipine is a new calcium ion antagonist with vasodilating properties which has been shown to be effective in the treatment of hypertension and angina." | 5.27 | Acute and chronic effects of nicardipine on systolic and diastolic left ventricular performance in patients with heart failure: a pilot study. ( Caruana, MP; Kohli, RS; Lahiri, A; Raftery, EB; Robinson, CW, 1986) |
| "Felodipine is a new calcium antagonist with a high degree of vascular selectivity." | 5.27 | Studies with felodipine in congestive heart failure. ( Jewitt, DE; Timmis, AD, 1985) |
| " Although the safety profile of nifedipine has been generally regarded as favorable, a few reports of clinically significant adverse effects in specific patient groups have appeared in the literature." | 5.26 | Nifedipine therapy in angina pectoris: evaluation of safety and side effects. ( Terry, RW, 1982) |
| " Long-term therapy with aerosolized iloprost (long-acting PGI(2) analog) resulted in unequivocal clinical improvement from a state of immobilization and severe resting dyspnea in a patient with decompensated right heart failure." | 5.09 | Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. ( Ghofrani, HA; Grimminger, F; Olschewski, H; Schermuly, R; Seeger, W; Temmesfeld-Wollbruck, B; Walmrath, D, 1999) |
| "In 61 patients with NYHA IV class chronic congestive heart failure, treated in succession with digoxin (D) and furosemide (F) for two weeks, with D+F and isosorbide dinitrate (S) or nifedipine (N) for two weeks, with D+F+S or N without C for two weeks, clinical status, chest X-ray picture and two dimensional echocardiography were evaluated at the end of each stage of the treatment." | 5.07 | [Results of conventional treatment of severe congestive heart failure with vasodilators]. ( Cholewa, M; Dryjański, T; Gawor, Z; Górski, L; Kaczkowska-Marusik, E; Kuś, W; Markiewicz, K, 1992) |
| "We performed a prospective, randomized, double-blind, crossover study to compare the efficacy and safety of vasodilation with the calcium entry blocker nifedipine with that of isosorbide dinitrate (ISDN) and their combination as treatment for heart failure." | 5.06 | A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. ( Amin, J; Elkayam, U; Mehra, A; Rahimtoola, SH; Vasquez, J; Weber, L, 1990) |
| "By means of impedance- and mechanocardiography the effect of the calcium-channel blocker nisoldipine on the circadian course of hemodynamic parameters was measured in a placebo-controlled randomized double-blind study in 18 patients with heart failure (NYHA II)." | 5.06 | [Mechano- and impedance cardiography parameters in patients with heart failure in administration of a calcium antagonist. The significance of the Heather index]. ( Kirch, W; Linde, M; Ohnhaus, EE, 1989) |
| "18 patients with II NYHA class chronic congestive heart failure (CCHF) had been given nifedipine (Cordipin) 54." | 5.06 | [Evaluation of the effect of nifedipine in patients with chronic congestive heart failure]. ( Bechler-Lisińska, J; Broks-Bratkowska, B; Cholewa, M; Dryjański, T; Gawor, Z; Górski, L; Markiewicz, K, 1989) |
| "We evaluated the effects of intravenous hydralazine (5 to 30 mg) and oral nifedipine (20 to 80 mg) on plasma catecholamines, renin, and aldosterone in 18 patients with severe chronic heart failure." | 5.06 | Neurohumoral consequences of vasodilator therapy with hydralazine and nifedipine in severe congestive heart failure. ( Elkayam, U; Freidenberger, L; Hsueh, W; Rahimtoola, SH; Roth, A; Weber, L, 1986) |
| "Afterload reduction with angiotensin-converting enzyme inhibitors (ACE-inhibitors), such as captopril, is an established therapeutic measure in the adjunctive treatment of severe chronic heart failure." | 5.06 | [Clinical and hemodynamic effects of nisoldipine and captopril in heart failure: a double-blind comparative study of long and short-term effects]. ( Figulla, HR; Kreuzer, H; Luig, H; Nieschlag, F, 1987) |
| "In a placebo controlled double-blind study including 10 patients with heart failure the nisoldipine/digoxin interaction was studied." | 5.06 | Influence of nisoldipine on haemodynamic effects and plasma levels of digoxin. ( Dylewicz, P; Hutt, HJ; Kirch, W; Ohnhaus, EE; Santos, SR; Stenzel, J, 1986) |
| " Oral nifedipine is now considered an alternative first-line therapy, along with intravenous hydralazine and labetalol for women presenting with pre-eclampsia." | 4.98 | Focused Update on Pharmacologic Management of Hypertensive Emergencies. ( Broscious, R; Devabhakthuni, S; Noel, ZR; Watson, K, 2018) |
| " hypertension clinical trial databases for amlodipine (Norvasc) and nifedipine in the gastrointestinal therapeutic system (GITS) formulation (Procardia XL)." | 4.80 | Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients. ( Kloner, RA; Levenstein, M; Materson, BJ; Vetrovec, GW, 1998) |
| " In order to evaluate the relationship between the mode of action of nitrates at cellular level and their vasodilatory effectiveness, we studied the circulatory response of the forearm to isosorbide dinitrate and the influence of nitroglycerin on free calcium concentration in the platelets in 10 patients with chronic heart failure." | 4.78 | Relationship between the inhibition of receptor-induced increase in cytosolic free calcium concentration and the vasodilator effects of nitrates in patients with congestive heart failure. ( Baldenkov, GN; Mazaev, AV; Mukharliamov, NM; Negrescu, EV; Sazonova, LN; Tkachuk, VA, 1990) |
| " Verapamil is extremely effective in patients with supraventricular tachyarrhythmias, hypertrophic cardiomyopathy, and the various anginal syndromes, but it appears to be ineffective or possibly even deleterious in those with pulmonary hypertension, congestive heart failure of any cause, and Raynaud's phenomenon or disease." | 4.77 | Calcium antagonists in patients with cardiovascular disease. Current perspectives. ( Hillis, LD; Winniford, MD, 1985) |
| " The second stage involved the evaluation of the biological activity of the steroid-pyridine derivative on left ventricular pressure using a model of heart failure in the absence or presence of the drugs, such as flutamide, tamoxifen, prazosin, metoprolol, indomethacin, and nifedipine." | 4.12 | Synthesis and Biological Activity of the Pyridine-hexacyclic-steroid Derivative on a Heart Failure Model. ( Francisco, DC; Idalia, AC; Lauro, FV; Magdalena, AR; Marcela, RN; Maria, LR; Tomas, LG; Virginia, MM, 2022) |
| "Little is known about the effect of nonsteroidal anti-inflammatory drugs (NSAIDs), thiazolidinediones (TZDs), nifedipine and nondihydropyridine calcium channel blockers (CCBs) usage on the risk of all-cause hospitalization among seniors with heart failure (HF)." | 3.85 | Effect of contraindicated drugs for heart failure on hospitalization among seniors with heart failure: A nested case-control study. ( Girouard, C; Grégoire, JP; Moisan, J; Poirier, P, 2017) |
| "This study was designed to examine the hypothesis that a calcium channel blocker nifedipine (CCB) could enhance the cardioprotective effect of an angiotensin-ll receptor blocker candesartan (ARB) in the treatment for heart failure." | 3.73 | Nifedipine enhances the cardioprotective effect of an angiotensin-II receptor blocker in an experimental animal model of heart failure. ( Hayashi, T; Horimoto, H; Inamoto, S; Kitaura, Y; Mieno, S; Mori, T; Okabe, M; Okuda, N, 2005) |
| "854(DFAC), where C(cr) is the estimated creatinine clearance (ml/min); CCB=1 for concomitant administration of calcium channel blockers and CCB=zero otherwise; CHF=1 for the patients with congestive heart failure and CHF=zero otherwise; SPI=1 for concomitant administration of spironolactone and SPI=zero otherwise; DFAC=1 for administration of a half-tablet of digoxin and DFAC=zero otherwise." | 3.71 | Pharmacoepidemiologic detection of calcium channel blocker-induced change on digoxin clearance using multiple trough screen analysis. ( Goto, Y; Higuchi, S; Minemoto, M; Ohdo, S; Suematsu, F; Yukawa, E; Yukawa, M, 2002) |
| " Here, we compare the effects of Y-27632 and nifedipine on the vasoconstrictor response of the femoral artery in heart failure." | 3.71 | Enhancement of Rho/Rho-kinase system in regulation of vascular smooth muscle contraction in tachycardia-induced heart failure. ( Hisaoka, T; Kobayashi, S; Kohno, M; Matsuzaki, M; Ohkusa, T; Ono, K; Suetsugu, M; Yamada, J; Yano, M, 2001) |
| "Past studies have suggested that amlodipine, a dihydropyridine L-type Ca(2+) channel antagonist, may exert useful effects in congestive heart failure (CHF)." | 3.71 | Comparison of amlodipine or nifedipine treatment with developing congestive heart failure: effects on myocyte contractility. ( Clair, MJ; Gay, DM; Goldberg, A; Hendrick, JW; Jolly, JR; King, MK; McElmurray, JH; Mukherjee, R; Patterson, TM; Spinale, FG, 2001) |
| " Although nifedipine-treated patients had a higher prevalence of coronary heart disease diagnosis than diuretic-treated patients (52% versus 35%), their relative risk of mortality was 0." | 3.70 | Mortality in the Jerusalem 70-year-olds longitudinal study: does nifedipine have a role? ( Bursztyn, M; Ginsberg, G; Maaravi, Y; Spilberg, O; Stessman, J, 1999) |
| "The effect of nifedipine on ventriculoarterial coupling was examined in 8 patients with old myocardial infarction who showed a depressed ejection fraction (37 +/- 7%)." | 3.69 | The effect of nifedipine on ventriculoarterial coupling in old myocardial infarction. ( Fujii, T; Hiro, T; Katayama, K; Kohno, M; Matsuzaki, M; Miura, T; Seki, K; Yano, M, 1996) |
| "The impact of intravenous infusion of nifedipine and nitroglycerin on invasive central hemodynamic parameters and microcirculation was compared in 94 patients with acute myocardial infarction complicated by heart failure." | 3.68 | [Heart failure in acute myocardial infarction: comparing infusions of nifedipine and nitroglycerin]. ( Gruzdev, AK; Kosminskiĭ, PG; Lazarev, IA; Magnitskiĭ, AV; Sidorenko, BA; Vaniev, SB; Vasechkin, SS, 1992) |
| "The acute hemodynamic effects of nilvadipine, a newly synthesized calcium channel blocker, were studied in 12 patients with congestive heart failure." | 3.68 | Acute hemodynamic effects of nilvadipine, a new calcium channel blocker, in patients with congestive heart failure. ( Aoyagi, T; Iizuka, M; Ikenouchi, H; Matsui, H; Mochizuki, T; Momomura, S; Sato, H; Serizawa, T; Sugimoto, T, 1990) |
| "Haemodynamic effects of nifedipine (NIF) tablets were studied for 12 h in 10 patients with severe congestive heart failure due to ischaemic heart disease." | 3.68 | Haemodynamic effects of slow-release nifedipine in severe congestive heart failure due to ischaemic heart disease. ( Rossi, A; Ziacchi, V, 1990) |
| "In 22 of 27 cases of congestive heart failure (CHF) treated with nifedipine (NIF), significant improvements in resting hemodynamics were noticed." | 3.68 | Nifedipine pharmacodynamics and pharmacokinetics in treatment of congestive heart failure. ( Chen, DG; Chen, K; Feng, QP; Wang, ZQ, 1990) |
| "To elucidate the hemodynamic responses to sublingual nifedipine administration during exercise and recovery in congestive heart failure, 16 patients with dilated cardiomyopathy (DCM) and 11 controls were studied using supine bicycle exercise testing." | 3.68 | [Hemodynamic responses to sublingual nifedipine during exercise and recovery in congestive heart failure]. ( Amioka, H; Hashimoto, M; Kajiyama, G; Kawagoe, T; Matsuura, H; Morichika, N; Nakagawa, H; Okamoto, M; Tsuchioka, Y; Yamagata, T, 1990) |
| "Clinical, hemodynamic and neurohumoral data are available supporting the validity of a differentiated approach to administration of combined treatment with furosemide, digoxin and calcium antagonists nifedipine and verapamil in advanced-aged patients with hypertension complicated by circulatory disorders." | 3.68 | [Evaluation of the effectiveness of calcium antagonists combined with digoxin and furosemide in hypertension complicated by circulatory insufficiency in elderly patients]. ( Orynchak, MA, 1990) |
| "The effect of 2-month treatment with isosorbide dinitrate (120 mg day-1), nifedipine (2 x 20 mg day-1) and their combination has been assessed in 16 patients with mild to moderate chronic cardiac failure." | 3.68 | Long-term effect of isosorbide dinitrate and nifedipine, singly and in association, in patients with chronic heart failure. ( Feuereisl, R; Jezek, V; Jezková, J; Michaljanic, A; Niederle, P, 1990) |
| "The acute hemodynamic response to a single oral dose of nitrendipine (10-20 mg) was evaluated in eight subjects with severe chronic congestive heart failure during right heart catheterization." | 3.67 | Acute hemodynamic effects of nitrendipine in chronic congestive heart failure. ( Cohn, JN; Levine, TB; Olivari, MT, 1984) |
| "The acute effect of nifedipine (Adalat, Bayer) was evaluated in 54 men with a history of transmural myocardial infarction." | 3.67 | Evaluation of the effect of nifedipine in men after myocardial infarction. ( Jedlicka, J; Kidéry, J; Málek, I; Nestával, A; Oppelt, A; Stanĕk, V, 1984) |
| "The central and renal hemodynamic effects of nifedipine were evaluated in nine patients with severe chronic congestive heart failure." | 3.67 | Renal hemodynamic effects of vasodilation with nifedipine and hydralazine in patients with heart failure. ( Campese, VM; Elkayam, U; Massry, SG; Rahimtoola, SH; Weber, L, 1984) |
| "Ten patients with moderate to severe congestive heart failure (CHF) underwent central and regional hemodynamic measurements at rest and central hemodynamic measurements during exercise before and after the oral administration of nifedipine (0." | 3.67 | Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow. ( Hermiller, J; Huss, P; Leier, CV; Magorien, RD; Pacht, KD; Patrick, TJ; Unverferth, DV, 1984) |
| "The effects of intravenous nicardipine (10 mg) on some aspects of left ventricular function have been studied with a radioisotope method in 10 male patients in chronic heart failure (NYHA Class II and III)." | 3.67 | Intravenous nicardipine in patients with chronic heart failure: a nuclear stethoscope study. ( Caruana, MP; Harlow, BJ; Kohli, RS; Lahiri, A; Raftery, EB; Robinson, CW; Tovey, J, 1984) |
| "The use of nifedipine in patients with hypertension, heart failure, and acute myocardial infarction is discussed." | 3.67 | Nifedipine in hypertension and heart failure. ( Matsui, S; Murakami, E; Murakami, H; Takekoshi, N, 1984) |
| " Therefore, intravenous diltiazem (100 to 200 micrograms/kg per min infusion) was administered for 40 minutes followed by oral diltiazem (90 to 120 mg/8 hours) for 24 hours to patients with advanced congestive heart failure (New York Heart Association class III to IV, mean ejection fraction 26 +/- 4 [SD])." | 3.67 | Beneficial hemodynamic effects of intravenous and oral diltiazem in severe congestive heart failure. ( O'Rourke, RA; Porter, CB; Starling, MR; Walsh, RW, 1984) |
| "The hemodynamic effects of 20 to 40 mg of oral nifedipine were compared with those of intravenous nitroprusside in 11 patients with severe chronic congestive heart failure (CHF)." | 3.67 | Comparison of hemodynamic responses to nifedipine and nitroprusside in severe chronic congestive heart failure. ( Elkayam, U; McKay, CR; Rahimtoola, SH; Torkan, B; Weber, L, 1984) |
| "The hemodynamic response to a similar reduction of systemic vascular resistance after nifedipine and hydralazine administration was compared in a randomized crossover protocol in patients with severe chronic congestive heart failure (CHF)." | 3.67 | Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure. ( Elkayam, U; McKay, CR; Rahimtoola, SH; Weber, L, 1984) |
| " The combination of nitrendipine plus enalapril was also examined in ischemic failure and in rats with spontaneous hypertension." | 3.67 | Enalapril in experimental hypertension and acute heart failure: comparison with calcium channel blockers. ( Adkins, E; Emmert, S; Ludden, CT; Ribeiro, LG; Seymour, AA; Sweet, CS, 1986) |
| "The haemodynamic effects of nifedipine (20 mg sublingually) were studied in 40 patients with acute myocardial infarction within 18 h of the onset of symptoms." | 3.67 | Nifedipine following acute myocardial infarction--dependence of response on baseline haemodynamic status. ( Jackson, NC; Nelson, GI; Reynolds, GW; Silke, B; Taylor, SH; Verma, SP; Wilson, JA, 1987) |
| "The acute hemodynamic effects of intravenous nisoldipine were studied in 10 patients with severe congestive heart failure." | 3.67 | Intravenous nisoldipine in severe congestive heart failure. ( Armstrong, PW; Frankel, D; Karlinsky, SJ; Moe, GW, 1988) |
| "Twenty-seven cases of congestive heart failure (CHF) were treated with nifedipine (Nif) 20 mg po." | 3.67 | [Pharmacodynamics and pharmacokinetics of nifedipine in patients with congestive heart failure]. ( Chen, DG; Chen, K; Feng, QP; Wang, ZQ, 1989) |
| "As many as 52 patients with essential hypertension aggravated by circulatory failure were examined for the clinical, hemodynamic and neurohumoral parameters during furosemide stimulation." | 3.67 | [The efficacy of calcium antagonists in circulatory failure in elderly patients with hypertension]. ( Orynchak, MA, 1989) |
| "Nisoldipine, a calcium entry blocker, was given to 10 patients with congestive heart failure." | 3.67 | Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure. ( Barjon, JN; Bichet, D; De Champlain, J; Juneau, C; Rouleau, JL, 1987) |
| " On this basis, functional and therapeutical regimen of regression of cardiac hypertrophy (prazosin, clonidine, nifedipine) are analyzed in concentric as well as in excentric hypertrophy in patients with arterial hypertension." | 3.67 | [Progression and regression of heart hypertrophy in arterial hypertension: pathophysiology and clinical aspects]. ( Strauer, BE, 1985) |
| "Nitroglycerin and nifedipine have been suggested as useful agents in the therapy of congestive heart failure." | 3.67 | A comparative evaluation of hemodynamic and neurohumoral effects of nitroglycerin and nifedipine in congestive heart failure. ( Armstrong, PW; Lefkowitz, CA; Moe, GW, 1987) |
| "Nifedipine was used successfully in nine patients with refractory hypertension and left ventricular hypertrophy who had symptoms of congestive heart failure despite preserved left ventricular systolic function." | 3.67 | Nifedipine in severely hypertensive patients with congestive heart failure and preserved ventricular systolic function. ( Dzau, VJ; Given, BD; Lee, TH; Stone, PH, 1985) |
| "A patient with congestive heart failure and normal renal function developed anuria during treatment with nifedipine." | 3.67 | Acute renal failure during nifedipine therapy in a patient with congestive heart failure. ( Chalopin, JM; Eicher, JC; Louis, P; Morelon, P; Rifle, G; Tanter, Y, 1988) |
| "Sublingual administration of nifedipine (N) at a dose of 20 mg to 8 persons without cardiovascular and renal pathology and to 19 patients with congestive heart failure (CHF) increased renal excretion of sodium (by an average of 51." | 3.67 | [Effect of nifedipine on renal activity]. ( Donskova, TV; Kolomiets, VV; Merzon, AK; Merzon, KA; Zolotov, NA, 1988) |
| " Cardiac catheterization revealed a primary pulmonary hypertension sensible to nifedipine, but after the initial favourable results the clinical course rapidly went down and the child died from right sided congestive heart failure." | 3.67 | Unexplained plexogenic pulmonary arteriopathy: an unusual rapidly progressive case in childhood. ( Ammirati, A; Coli, A; Dina, MA, 1988) |
| "In order to select the optimal vasodilator for the treatment of patients with congestive heart failure (CHF), the acute effects of three vasodilators (isosorbide dinitrate (ISDN) 5 mg, nifedipine 10 mg, and prazosin 1 mg) on peripheral capacitance and resistance vessels (CV and RV) were evaluated by a newly devised radionuclear technique (Study 1)." | 3.67 | Radionuclear measurement of peripheral hemodynamics in selection of vasodilators for treatment of heart failure. ( Fujisue, R; Iwasaki, T; Ohyanagi, M; Todo, Y, 1988) |
| "Twelve patients referred for evaluation of functional class 4 heart failure as classified by the New York Heart Association underwent treatment with nifedipine after other regimens proved unsatisfactory." | 3.67 | Improvement in NYHA functional class 4 congestive heart failure patients with nifedipine: a hemodynamic evaluation. ( Olson, L; Vlay, SC, 1988) |
| "We studied the acute effects of nisoldipine, a new second-generation calcium channel-blocking drug, on cardiac hemodynamics and left ventricular (LV) contractility in 10 patients with grade 2 to 4 cardiac failure." | 3.67 | Effect of the second-generation calcium channel blocker nisoldipine on left ventricular contractility in cardiac failure. ( Flugelman, MY; Halon, DA; Hardoff, R; Lewis, BS; Merdler, A; Shefer, A, 1988) |
| "The systemic and coronary hemodynamic and neurohumoral effects of nisoldipine, a calcium antagonist drug with high vascular specificity, were investigated in 17 patients with chronic congestive heart failure (CHF)." | 3.67 | Arterial vasodilator, systemic and coronary hemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathy. ( Buehler, FR; Burkart, F; Erne, P; Kiowski, W; Mueller, J; Pfisterer, M, 1987) |
| "The hemodynamic effects of increasing oral doses of nifedipine (10 to 30 mg) were studied in 12 patients who had low output heart failure." | 3.67 | Characterization of the dose-concentration-dependent hemodynamic effects of nifedipine in heart failure. ( Gengo, FM; Green, JA; Nara, AR, 1987) |
| "The hemodynamic response to vasodilation induced by the new calcium channel antagonist nicardipine was studied in 10 patients with severe, chronic congestive heart failure." | 3.67 | Effect of nicardipine on rest and exercise hemodynamics in chronic congestive heart failure. ( Cody, RJ; Kubo, SH; Lystash, J; Ryman, KS; Stone, G, 1986) |
| "To determine if the addition of preload reduction with nitrates would potentiate the acute vasodilator actions of nifedipine, we titered intravenous nitroglycerin in seven patients with severe congestive heart failure after they received a single oral dose of nifedipine." | 3.67 | Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure. ( Cody, RJ; Fox, SC; Kubo, SH; Prida, XE, 1985) |
| "The systemic and coronary haemodynamic effects of felodipine were evaluated at rest and during stress induced atrial pacing in fourteen patients with chronic cardiac failure, secondary to coronary heart disease." | 3.67 | Felodipine in ventricular dysfunction. ( Hutton, I; Tweddel, AC, 1986) |
| "To evaluate the short-term hemodynamic and neuroendocrine effects of nifedipine in heart failure, it was compared with nitroprusside, a balanced vasodilator without known inotropic effect, in equihypotensive doses during right and left heart catheterization in nine patients with heart failure." | 3.67 | Inotropic, vascular and neuroendocrine effects of nifedipine in heart failure: comparison with nitroprusside. ( Barry, WH; Colucci, WS; Fifer, MA; Jaski, BE; Lorell, BH, 1985) |
| "Nine patients with chronic, severe (New York Heart Association class III to IV) congestive heart failure were studied to determine the acute effects of 10 mg of sublingual nifedipine on left ventricular (LV) function." | 3.67 | Sublingual nifedipine: acute effects in severe chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy. ( Bass, TA; Conetta, DA; Miller, AB, 1985) |
| "The acute hemodynamic effects of 20 to 50 mg of orally administered nifedipine were evaluated in 31 patients with severe chronic congestive heart failure (CHF) and the results were analyzed according to the response of the cardiac index (CI)." | 3.67 | Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure. ( Elkayam, U; McKay, C; Rahimtoola, S; Weber, L, 1985) |
| "The effects of oral nifedipine on limb hemodynamics were studied in 7 normal subjects, 8 patients with congestive heart failure and 2 patients who underwent sympathectomy of unilateral limb." | 3.67 | Effects of nifedipine on forearm vascular resistance and venous capacitance in normal subjects and in patients with congestive heart failure. ( Hattori, N; Ikeda, T; Kitamura, T; Nakamura, Y; Takata, S; Yamamoto, M, 1985) |
| "A single administration of verapamil (5 mg infused intravenously) and nifedipin (20 mg sublingually) in 31 patients with chronic cardiac failure of stage I and IIA decreased the levels of ionizing calcium (Ca2+) in the blood serum (the maximum reduction averaged 19." | 3.67 | [Effect of verapamil and nifedipine on the fractional composition of calcium in the blood serum]. ( Merzon, KA, 1985) |
| " Two cases and a review of the literature relating to treatment of hypertensive emergencies with nifedipine are presented." | 3.67 | Nifedipine in the management of hypertensive emergencies: report of two cases and review of the literature. ( Checcio, LM; Cohan, JA, 1985) |
| "The temporal hemodynamic effects of oral nifedipine after a single dose of 20 to 40 mg were evaluated in 11 patients with severe chronic congestive heart failure (left ventricular ejection fraction 0." | 3.66 | Acute hemodynamic effect of oral nifedipine in severe chronic congestive heart failure. ( Berman, D; Elkayam, U; Rahimtoola, SH; Torkan, B; Weber, L, 1983) |
| "Clinical experience with calcium antagonists in congestive heart failure has, to date, been mainly restricted to the use of nifedipine but there is either no or only a limited extent of information available on diltiazem and verapamil." | 3.66 | Calcium antagonists in heart failure. ( Camerini, F; Klugmann, S; Salvi, A, 1983) |
| "The acute haemodynamic effects of nifedipine (10 mg sublingually) and isosorbide dinitrate (5 mg sublingually) were compared in 13 patients with heart failure due to acute myocardial infarction." | 3.66 | Comparison of acute haemodynamic effects of nifedipine and isosorbide dinitrate in patients with heart failure following acute myocardial infarction. ( Bracchetti, D; Cantelli, I; Naccarella, F; Pavesi, PC, 1981) |
| "Nifedipine, a potent coronary vasodilator, was administered in a single sublingual dose of 20 mg to eight patients with mild to moderate congestive heart failure." | 3.66 | Hemodynamic effects of nifedipine in congestive heart failure. ( Ito, T; Ito, Y; Matsumoto, S; Okabe, F; Sada, T; Sato, M; Sekine, I; Su, KM; Takahashi, M; Ueda, A, 1980) |
| "Hemodynamic response of nifedipine in 11 patients with congestive heart failure was examined." | 3.66 | Hemodynamic effects of sublingual nifedipine in congestive heart failure. ( Fujita, S; Hiramaru, Y; Kitano, E; Masuya, K; Matsui, S; Murakami, E; Murakami, H; Nomura, M; Saga, T; Takekoshi, N; Tsuji, S, 1979) |
| "Nifedipine was administered in a dose of 30 mg orally to 14 patients with coronary heart disease and clinical evidence of left heart failure." | 3.66 | [The effect of nifedipine on the pulmonary artery pressure in patients with coronary heart disease (author's transl)]. ( Beck, OA; Hochrein, H, 1978) |
| "The development of heart failure is uncommon in patients with stable angina, and even less so in the absence of an obvious precipitating factor." | 2.73 | The development of heart failure in patients with stable angina pectoris. ( de Brouwer, S; Erik Otterstad, J; Kirwan, BA; Lubsen, J; Poole-Wilson, PA; Sutton, GC; Vokó, Z, 2007) |
| " We conclude that the long-term administration of nilvadipine (16 mg daily) is neither effective nor harmful in the treatment of patients with chronic heart failure." | 2.67 | Long-term clinical effect of nilvadipine in patients with chronic heart failure: a double-blind placebo-controlled study. ( Hayashi, T; Hoki, N; Hori, M; Kamada, T; Karita, M; Kodama, K; Naka, M; Nanto, S; Sato, H; Yamada, Y, 1994) |
| "Fifteen congestive heart failure patients (NYHA: class III or IV) were enrolled in the study and were classified into two groups." | 2.67 | Hemodynamic comparison of combined therapy by nitroglycerin tape and ibopamine with combination of nitroglycerin tape and nifedipine. ( Itoh, H; Taniguchi, K; Tsujibayashi, T, 1990) |
| "In 50 patients with chronic congestive heart failure (CCHF, III or IV class), aged 62." | 2.67 | [Effect of vasodilator agents on the character and incidence of cardiac arrhythmia in chronic heart failure]. ( Bechler-Lisińska, J; Cholewa, M; Górski, L; Markiewicz, K, 1990) |
| "Calcium antagonists are used in the treatment of hypertension and angina." | 2.44 | The ACTION study: nifedipine in patients with symptomatic stable angina and hypertension. ( Coca, A; Sierra, C, 2008) |
| "Felodipine is a highly vascular selective calcium entry blocker, with a vascular selectivity ratio greater than 100, as shown experimentally." | 2.39 | Vascular selective calcium entry blockers in the treatment of cardiovascular disorders: focus on felodipine. ( Cheng, CP; Elvelin, L; Little, WC; Nordlander, M, 1995) |
| "Nilvadipine is a new calcium antagonist of the dihydropyridine type." | 2.38 | Pharmacodynamics of nilvadipine, a new dihydropyridine-type calcium antagonist. ( Honerjäger, P; Seibel, K, 1992) |
| "Even verapamil, however, has been shown to lead to hemodynamic improvement in some patients, at least after acute administration." | 2.38 | [Treatment of heart failure with calcium antagonists]. ( Dirschinger, J; Hall, D; Kraus, F; Rudolph, W, 1990) |
| "We examine all the congestive heart failure electronic health records of the largest medical center in Israel to discover whether, possibly, taking Adalat with other medications is associated with patient death." | 1.56 | A case study of applying text analysis to identify possible adverse drug interactions: The case of Adalat (Nifedipine). ( Ben-Assuli, O; Gefen, D; Klempfner, R; Robertson, N; Shlomo, N, 2020) |
| " We report two cases that developed cerebrovascular and cardiovascular adverse events associated with aggressive treatment of increased blood pressure by the use of sublingual nifedipine capsule." | 1.32 | Adverse events associated with aggressive treatment of increased blood pressure. ( Akay, S; Ayrik, C; Cevik, AA; Yanturali, S, 2004) |
| "Heart failure was induced by ligation of the left coronary artery." | 1.31 | Enhanced Ca2+-induced contractions and attenuated alpha-adrenoceptor responses in resistance arteries from rats with congestive heart failure. ( Bergdahl, A; Edvinsson, L; Hedner, T; Sun, XY; Valdemarsson, S, 2001) |
| "Myocyte apoptosis and muscle atrophy were significantly decreased with irbesartan compared with untreated CHF rats." | 1.31 | Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure. ( Angelini, A; Battista Ambrosio, G; Dalla Libera, L; Ravara, B; Rossini, K; Sandri, M; Thiene, G; Vescovo, G, 2001) |
| "Type 2 diabetes is increasing in prevalence and is predominantly managed in general practice." | 1.30 | A cautionary tale. ( Phillips, PJ; Popplewell, PY; Tallis, GA, 1997) |
| "In thapsigargin-treated high-Na cells, tonic contraction magnitude increased exponentially with test-potential." | 1.30 | Contribution of reverse-mode sodium-calcium exchange to contractions in failing human left ventricular myocytes. ( Houser, SR; Jeevanandam, V; Margulies, KB; Mattiello, JA, 1998) |
| "Postmortem examination confirmed congestive heart failure with chronic, fibrosing cardiomyopathy similar to that in other gorillas." | 1.30 | Chronic hypertension with subsequent congestive heart failure in a western lowland gorilla (Gorilla gorilla gorilla). ( Barnhart, JS; Bell, MD; Miller, CL; Schwartz, AM, 1999) |
| "Nisoldipine produced an increase in LV filling fraction from 36 +/- 17% to 43 +/- 20% (p = 0." | 1.28 | Effect of the second-generation calcium channel blocking drug nisoldipine on diastolic left ventricular dysfunction in heart failure. ( Flugelman, MY; Halon, DA; Hardoff, R; Lewis, BS; Merdler, A; Shefer, A, 1989) |
| "Nifedipine was administered to near-term rats and cardiovascular morphology of the fetus was studied with a rapid whole-body freezing technique." | 1.28 | Fetal cardiovascular effects of nifedipine in rats. ( Momma, K; Takao, A, 1989) |
| "Milrinone (Win 47203) is a dipyridine related to amrinone, which is about 20-50 times as effective as amrinone when assayed on cardiac contractility." | 1.27 | The search for a digitalis substitute II milrinone (Win 47203). Its action on the heart-lung preparation of the dog. ( Farah, A; Kabela, E; Mendez, R; Pastelin, G, 1983) |
| "Digoxin activity was measured on the eighth, ninth and sixteenth day of treatment by Rubidium 86 uptake in erythrocytes." | 1.27 | [Increased digitalis-like activity in combined administration of calcium antagonists and digitalis preparations]. ( Balestrazzi, M; Chiarappa, R; De Cesaris, R; Ranieri, G, 1983) |
| "were studied in 15 patients with chronic congestive heart failure due to ischemic heart disease or cardiomyopathy." | 1.27 | Hemodynamic effects of nisoldipine in chronic congestive heart failure. ( Kreuzer, H; Vogt, A, 1983) |
| "Felodipine is a new calcium antagonist with a high degree of vascular selectivity." | 1.27 | Acute haemodynamic and metabolic effects of felodipine in congestive heart failure. ( Campbell, S; Jewitt, DE; Monaghan, MJ; Timmis, AD; Walker, L, 1984) |
| "Nifedipine is an effective agent for the treatment of postinfarction heart failure accompanied with high peripheral resistance." | 1.27 | [Use of nifedipine for treating heart failure in the subacute period of myocardial infarct in patients over 60]. ( Chistova, VS; Glezer, MG; Iakovlev, SV; Lazutin, VK; Sergeeva, EV, 1987) |
| "Confusion and sleep disorders constitute 8 cases." | 1.27 | Nifedipine--a survey of adverse effects. Four years' reporting in Sweden. ( Myrhed, M; Wiholm, BE, 1986) |
| "Nicardipine is a new calcium ion antagonist with vasodilating properties which has been shown to be effective in the treatment of hypertension and angina." | 1.27 | Acute and chronic effects of nicardipine on systolic and diastolic left ventricular performance in patients with heart failure: a pilot study. ( Caruana, MP; Kohli, RS; Lahiri, A; Raftery, EB; Robinson, CW, 1986) |
| "Nicardipine is a new slow channel calcium blocker." | 1.27 | The acute haemodynamic effects of nicardipine in patients with chronic left ventricular failure. ( Evans, TR; Greenbaum, RA; Wan, S, 1986) |
| "Nifedipine was associated with a decrease in systolic blood pressure (from 156 +/- 14 to 138 +/-13 mmHg), an increase in heart rate (from 73 +/- 13 to 81 +/- 8." | 1.27 | [Increase in liver circulation with nifedipine]. ( Kuhnen, R; Lüderitz, B; Nitsch, J, 1986) |
| "To determine whether nifedipine or diltiazem affect digoxin kinetics, glycoside plasma concentrations and renal excretion were measured before and during dosing in 23 patients with cardiac insufficiency achieving steady-state conditions." | 1.27 | Effects of nifedipine and diltiazem on plasma levels and renal excretion of beta-acetyldigoxin. ( Kuhlmann, J, 1985) |
| "Diltiazem was not significantly different from placebo." | 1.27 | Comparative effects of calcium-channel blocking agents on left ventricular function during acute ischemia in dogs with and without congestive heart failure. ( Epstein, SE; Patterson, RE; Urquhart, J, 1985) |
| "Felodipine is a new calcium antagonist with a high degree of vascular selectivity." | 1.27 | Studies with felodipine in congestive heart failure. ( Jewitt, DE; Timmis, AD, 1985) |
| " Although the safety profile of nifedipine has been generally regarded as favorable, a few reports of clinically significant adverse effects in specific patient groups have appeared in the literature." | 1.26 | Nifedipine therapy in angina pectoris: evaluation of safety and side effects. ( Terry, RW, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 150 (67.57) | 18.7374 |
| 1990's | 45 (20.27) | 18.2507 |
| 2000's | 17 (7.66) | 29.6817 |
| 2010's | 5 (2.25) | 24.3611 |
| 2020's | 5 (2.25) | 2.80 |
| Authors | Studies |
|---|---|
| Lauro, FV | 2 |
| Maria, LR | 2 |
| Francisco, DC | 2 |
| Marcela, RN | 2 |
| Virginia, MM | 2 |
| Magdalena, AR | 2 |
| Tomas, LG | 2 |
| Idalia, AC | 1 |
| Lee, HW | 1 |
| Huang, CC | 1 |
| Leu, HB | 1 |
| Lin, YJ | 1 |
| Alejandra, GE | 1 |
| Montserrat, MG | 1 |
| Gefen, D | 1 |
| Ben-Assuli, O | 1 |
| Shlomo, N | 1 |
| Robertson, N | 1 |
| Klempfner, R | 1 |
| Aali, E | 1 |
| Ghaznavi, H | 1 |
| Soltanpour, MS | 1 |
| Mahmoudian, M | 1 |
| Shafiei, M | 1 |
| Li, G | 1 |
| Wang, J | 1 |
| Liao, P | 1 |
| Bartels, P | 1 |
| Zhang, H | 1 |
| Yu, D | 1 |
| Liang, MC | 1 |
| Poh, KK | 1 |
| Yu, CY | 1 |
| Jiang, F | 1 |
| Yong, TF | 1 |
| Wong, YP | 1 |
| Hu, Z | 1 |
| Huang, H | 1 |
| Zhang, G | 1 |
| Galupo, MJ | 1 |
| Bian, JS | 1 |
| Ponniah, S | 1 |
| Trasti, SL | 1 |
| See, K | 1 |
| Foo, R | 1 |
| Hoppe, UC | 1 |
| Herzig, S | 1 |
| Soong, TW | 1 |
| Watson, K | 1 |
| Broscious, R | 1 |
| Devabhakthuni, S | 1 |
| Noel, ZR | 1 |
| Zimmer, J | 1 |
| Hawlitschek, C | 1 |
| Rabald, S | 1 |
| Hagendorff, A | 1 |
| Zimmer, HG | 1 |
| Rassler, B | 1 |
| Takahashi, F | 1 |
| Goto, M | 1 |
| Wada, Y | 1 |
| Hasebe, N | 1 |
| Girouard, C | 1 |
| Grégoire, JP | 1 |
| Poirier, P | 1 |
| Moisan, J | 1 |
| Sierra, C | 1 |
| Coca, A | 1 |
| Rodriguez, ME | 1 |
| Poindexter, BJ | 1 |
| Bick, RJ | 1 |
| Dasgupta, A | 1 |
| Suematsu, F | 1 |
| Yukawa, E | 1 |
| Yukawa, M | 1 |
| Minemoto, M | 1 |
| Ohdo, S | 1 |
| Higuchi, S | 1 |
| Goto, Y | 1 |
| Yanturali, S | 1 |
| Akay, S | 1 |
| Ayrik, C | 1 |
| Cevik, AA | 1 |
| Cleland, JG | 1 |
| Huan Loh, P | 1 |
| Freemantle, N | 1 |
| Clark, AL | 1 |
| Coletta, AP | 1 |
| Okuda, N | 1 |
| Hayashi, T | 2 |
| Mori, T | 1 |
| Inamoto, S | 1 |
| Okabe, M | 1 |
| Mieno, S | 1 |
| Horimoto, H | 1 |
| Kitaura, Y | 1 |
| Weber, MA | 1 |
| Sutton, GC | 1 |
| Erik Otterstad, J | 1 |
| Kirwan, BA | 2 |
| Vokó, Z | 1 |
| de Brouwer, S | 2 |
| Lubsen, J | 2 |
| Poole-Wilson, PA | 2 |
| Miller, MA | 1 |
| Masneri, DA | 1 |
| Herold, T | 1 |
| Dart, AM | 1 |
| Otterstad, JE | 1 |
| Parker, JD | 1 |
| Olivari, MT | 1 |
| Levine, TB | 1 |
| Cohn, JN | 1 |
| Cody, RJ | 6 |
| Laragh, JH | 2 |
| Atlas, SA | 1 |
| Case, DB | 1 |
| Opie, LH | 1 |
| Anastassiades, CJ | 1 |
| Anastassiades, C | 1 |
| Ziacchi, V | 2 |
| Rossi, A | 2 |
| Lomanto, B | 1 |
| Terry, RW | 1 |
| Krikler, DM | 1 |
| Rowland, E | 1 |
| Ellrodt, AG | 2 |
| Singh, BN | 1 |
| Swedberg, K | 1 |
| Benaim, R | 1 |
| Ameur, A | 1 |
| Bernier, A | 1 |
| Calvo, G | 1 |
| Braunwald, E | 2 |
| Moret, P | 1 |
| Guazzi, MD | 2 |
| Cipolla, C | 1 |
| Della Bella, P | 1 |
| Fabbiocchi, F | 1 |
| Montorsi, P | 1 |
| Sganzerla, P | 1 |
| Charlap, S | 1 |
| Frishman, WH | 1 |
| Timmis, AD | 4 |
| Smyth, P | 2 |
| Kenny, JF | 2 |
| Campbell, S | 3 |
| Jewitt, DE | 4 |
| Kerkez, SA | 1 |
| Magorien, RD | 3 |
| Leier, CV | 3 |
| Kolibash, AJ | 1 |
| Barbush, TJ | 1 |
| Unverferth, DV | 3 |
| Málek, I | 1 |
| Oppelt, A | 1 |
| Nestával, A | 1 |
| Kidéry, J | 1 |
| Jedlicka, J | 1 |
| Stanĕk, V | 1 |
| Brandt, D | 1 |
| Elkayam, U | 9 |
| Weber, L | 7 |
| Campese, VM | 1 |
| Massry, SG | 1 |
| Rahimtoola, SH | 6 |
| Patrick, TJ | 1 |
| Hermiller, J | 1 |
| Pacht, KD | 1 |
| Huss, P | 1 |
| Lahiri, A | 2 |
| Robinson, CW | 2 |
| Tovey, J | 1 |
| Caruana, MP | 2 |
| Kohli, RS | 2 |
| Harlow, BJ | 1 |
| Raftery, EB | 2 |
| Torkan, B | 2 |
| Berman, D | 1 |
| Prida, XE | 2 |
| Kubo, SH | 4 |
| Pastelin, G | 1 |
| Mendez, R | 1 |
| Kabela, E | 1 |
| Farah, A | 1 |
| De Cesaris, R | 1 |
| Balestrazzi, M | 1 |
| Chiarappa, R | 1 |
| Ranieri, G | 1 |
| Ito, H | 1 |
| Nakahara, K | 1 |
| Sato, M | 2 |
| Takada, N | 1 |
| Hirakawa, S | 1 |
| Vogt, A | 1 |
| Kreuzer, H | 2 |
| Monaghan, MJ | 1 |
| Walker, L | 1 |
| Murakami, E | 3 |
| Takekoshi, N | 3 |
| Matsui, S | 3 |
| Murakami, H | 3 |
| Svetoni, N | 1 |
| Spargi, T | 1 |
| Bellantonio, M | 1 |
| Lanzetta, T | 1 |
| Walsh, RW | 1 |
| Porter, CB | 1 |
| Starling, MR | 1 |
| O'Rourke, RA | 2 |
| McKay, CR | 2 |
| Kuhlmann, J | 2 |
| Marcin, S | 1 |
| Frank, KH | 1 |
| Robson, RH | 1 |
| Vishwanath, MC | 1 |
| Klugmann, S | 3 |
| Salvi, A | 2 |
| Camerini, F | 4 |
| Cantelli, I | 2 |
| Pavesi, PC | 2 |
| Parchi, C | 1 |
| Naccarella, F | 2 |
| Bracchetti, D | 2 |
| Low, RI | 1 |
| Takeda, P | 1 |
| Mason, DT | 1 |
| DeMaria, AN | 1 |
| Alves, LE | 1 |
| Rose, EP | 1 |
| Hanrath, P | 1 |
| Kremer, P | 1 |
| Bleifeld, W | 1 |
| Bethencourt, A | 1 |
| Medina, A | 1 |
| Elola, J | 1 |
| Macaya, C | 1 |
| Dalal, JJ | 1 |
| Griffiths, BE | 1 |
| Henderson, AH | 1 |
| Ludbrook, PA | 1 |
| Tiefenbrunn, AJ | 1 |
| Sobel, BE | 1 |
| Masuya, K | 2 |
| Nomura, M | 2 |
| Fujita, S | 2 |
| Tsuji, S | 2 |
| Chadani, T | 1 |
| Franciosa, JA | 1 |
| Fioretti, P | 1 |
| Salvi, AU | 1 |
| Schiavoni, G | 1 |
| Mazzari, M | 1 |
| Scabbia, E | 1 |
| Coppola, E | 1 |
| Domenichelli, B | 1 |
| Manzoli, U | 1 |
| Matsumoto, S | 1 |
| Ito, T | 1 |
| Sada, T | 1 |
| Takahashi, M | 1 |
| Su, KM | 1 |
| Ueda, A | 1 |
| Okabe, F | 1 |
| Sekine, I | 1 |
| Ito, Y | 1 |
| Brooks, N | 1 |
| Cattell, M | 1 |
| Pidgeon, J | 1 |
| Balcon, R | 1 |
| Little, WC | 2 |
| Cheng, CP | 2 |
| Hori, M | 2 |
| Sato, H | 2 |
| Karita, M | 1 |
| Kodama, K | 1 |
| Hoki, N | 1 |
| Naka, M | 1 |
| Nanto, S | 1 |
| Yamada, Y | 1 |
| Kamada, T | 2 |
| Lou, ZJ | 1 |
| Zhu, GL | 1 |
| Sun, XL | 1 |
| Lee, JM | 1 |
| Masuyama, T | 1 |
| Nagano, R | 1 |
| Yamamoto, K | 1 |
| Nariyama, K | 1 |
| Tanouchi, J | 1 |
| Sacchetti, A | 1 |
| McCabe, J | 1 |
| Torres, M | 1 |
| Harris, RL | 1 |
| Shotan, A | 1 |
| Mehra, A | 2 |
| Ostrzega, E | 1 |
| Mandelzweig, L | 1 |
| Goldbourt, U | 1 |
| Reicher-Reiss, H | 1 |
| Behar, S | 1 |
| Kaplinsky, E | 1 |
| Elvelin, L | 1 |
| Nordlander, M | 1 |
| Melvin, DB | 1 |
| Schima, H | 1 |
| Losert, UM | 1 |
| Wolner, E | 1 |
| Seki, K | 1 |
| Katayama, K | 1 |
| Hiro, T | 1 |
| Yano, M | 2 |
| Miura, T | 1 |
| Kohno, M | 3 |
| Fujii, T | 1 |
| Matsuzaki, M | 2 |
| Rajalingam, V | 1 |
| Chao, SM | 1 |
| Tan, CL | 1 |
| Tan, IK | 1 |
| Gómez, AM | 1 |
| Valdivia, HH | 1 |
| Cheng, H | 1 |
| Lederer, MR | 1 |
| Santana, LF | 1 |
| Cannell, MB | 1 |
| McCune, SA | 1 |
| Altschuld, RA | 1 |
| Lederer, WJ | 1 |
| Tallis, GA | 1 |
| Phillips, PJ | 1 |
| Popplewell, PY | 1 |
| White, CM | 1 |
| Kloner, RA | 1 |
| Vetrovec, GW | 1 |
| Materson, BJ | 1 |
| Levenstein, M | 1 |
| Mattiello, JA | 1 |
| Margulies, KB | 1 |
| Jeevanandam, V | 1 |
| Houser, SR | 2 |
| Schwinger, RH | 2 |
| Hoischen, S | 1 |
| Reuter, H | 1 |
| Hullin, R | 1 |
| Olschewski, H | 1 |
| Ghofrani, HA | 1 |
| Walmrath, D | 1 |
| Schermuly, R | 1 |
| Temmesfeld-Wollbruck, B | 1 |
| Grimminger, F | 1 |
| Seeger, W | 1 |
| Bursztyn, M | 1 |
| Ginsberg, G | 1 |
| Spilberg, O | 1 |
| Maaravi, Y | 1 |
| Stessman, J | 1 |
| Miller, CL | 1 |
| Schwartz, AM | 1 |
| Barnhart, JS | 1 |
| Bell, MD | 1 |
| Meyer, GJ | 1 |
| Banning, AP | 1 |
| Prendergast, B | 1 |
| Bergdahl, A | 1 |
| Valdemarsson, S | 1 |
| Sun, XY | 1 |
| Hedner, T | 1 |
| Edvinsson, L | 1 |
| Hisaoka, T | 1 |
| Ohkusa, T | 1 |
| Suetsugu, M | 1 |
| Ono, K | 1 |
| Yamada, J | 1 |
| Kobayashi, S | 1 |
| Nicolosi, AC | 1 |
| Kwok, CS | 1 |
| Contney, SJ | 1 |
| Olinger, GN | 1 |
| Bosnjak, ZJ | 1 |
| Dalla Libera, L | 1 |
| Ravara, B | 1 |
| Angelini, A | 1 |
| Rossini, K | 1 |
| Sandri, M | 1 |
| Thiene, G | 1 |
| Battista Ambrosio, G | 1 |
| Vescovo, G | 1 |
| McElmurray, JH | 1 |
| Mukherjee, R | 1 |
| Patterson, TM | 1 |
| Goldberg, A | 1 |
| King, MK | 1 |
| Hendrick, JW | 1 |
| Gay, DM | 1 |
| Clair, MJ | 1 |
| Jolly, JR | 1 |
| Spinale, FG | 1 |
| Piacentino, V | 1 |
| Gaughan, JP | 1 |
| Gennari, C | 1 |
| Borrello, G | 1 |
| Montagnani, M | 1 |
| Galli, M | 1 |
| Nuti, R | 1 |
| Loré, F | 1 |
| Hiramaru, Y | 1 |
| Kitano, E | 1 |
| Saga, T | 1 |
| Campa, PP | 1 |
| Speca, G | 1 |
| De Curtis, G | 1 |
| Pecce, P | 1 |
| Beck, OA | 1 |
| Hochrein, H | 1 |
| Clark, RE | 1 |
| Ferguson, TB | 1 |
| West, PN | 1 |
| Shuchleib, RC | 1 |
| Henry, PD | 1 |
| Honerjäger, P | 1 |
| Seibel, K | 1 |
| Kosminskiĭ, PG | 1 |
| Vaniev, SB | 1 |
| Vasechkin, SS | 1 |
| Lazarev, IA | 1 |
| Gruzdev, AK | 1 |
| Magnitskiĭ, AV | 1 |
| Sidorenko, BA | 2 |
| Portaluppi, F | 1 |
| Montanari, L | 1 |
| Ferlini, M | 1 |
| Vergnani, L | 1 |
| Bagni, B | 1 |
| Degli Uberti, EC | 1 |
| Mareev, VIu | 1 |
| Kazeĭ, DV | 1 |
| Ageev, FT | 1 |
| Shevliagin, SA | 1 |
| Grigor'iants, RA | 1 |
| Markiewicz, K | 3 |
| Cholewa, M | 3 |
| Górski, L | 3 |
| Gawor, Z | 2 |
| Kuś, W | 1 |
| Kaczkowska-Marusik, E | 1 |
| Dryjański, T | 2 |
| Ikenouchi, H | 1 |
| Aoyagi, T | 1 |
| Matsui, H | 1 |
| Mochizuki, T | 1 |
| Momomura, S | 1 |
| Serizawa, T | 1 |
| Iizuka, M | 1 |
| Sugimoto, T | 1 |
| Taniguchi, K | 1 |
| Tsujibayashi, T | 1 |
| Itoh, H | 1 |
| Gradman, AH | 1 |
| Cheng, TO | 1 |
| Khrustalev, OA | 1 |
| Berkovskiĭ, ML | 1 |
| Negrescu, EV | 1 |
| Sazonova, LN | 2 |
| Baldenkov, GN | 1 |
| Mukharliamov, NM | 1 |
| Mazaev, AV | 1 |
| Tkachuk, VA | 1 |
| Zhilin, SV | 1 |
| Vorob'ev, BI | 1 |
| Kastanaian, AA | 1 |
| Masalitinova, IV | 1 |
| Chen, DG | 3 |
| Feng, QP | 3 |
| Wang, ZQ | 2 |
| Chen, K | 2 |
| Yamagata, T | 1 |
| Okamoto, M | 1 |
| Hashimoto, M | 1 |
| Amioka, H | 1 |
| Nakagawa, H | 1 |
| Morichika, N | 1 |
| Kawagoe, T | 1 |
| Tsuchioka, Y | 1 |
| Matsuura, H | 1 |
| Kajiyama, G | 1 |
| Böhm, M | 1 |
| Erdmann, E | 1 |
| Bechler-Lisińska, J | 2 |
| Hall, D | 1 |
| Dirschinger, J | 1 |
| Kraus, F | 1 |
| Rudolph, W | 1 |
| Orynchak, MA | 2 |
| Gorb, IuG | 2 |
| Seab, KhK | 1 |
| Mikliaev, IIu | 1 |
| Amin, J | 1 |
| Vasquez, J | 1 |
| Jezek, V | 1 |
| Jezková, J | 1 |
| Michaljanic, A | 1 |
| Niederle, P | 1 |
| Feuereisl, R | 1 |
| Degtiarev, OA | 1 |
| Ivanov, AI | 1 |
| Sotskova, TV | 1 |
| Mikerova, TM | 1 |
| Morrison, DA | 1 |
| Gay, RG | 1 |
| Feldshon, D | 1 |
| Sampliner, RE | 1 |
| Sorkin, EM | 1 |
| Clissold, SP | 1 |
| Brogden, RN | 1 |
| Sinitsyn, SP | 1 |
| Colucci, WS | 3 |
| Wright, RF | 1 |
| Sweet, CS | 1 |
| Ludden, CT | 1 |
| Adkins, E | 1 |
| Seymour, AA | 1 |
| Emmert, S | 1 |
| Ribeiro, LG | 1 |
| Verma, SP | 1 |
| Silke, B | 1 |
| Taylor, SH | 1 |
| Wilson, JA | 1 |
| Reynolds, GW | 1 |
| Nelson, GI | 1 |
| Jackson, NC | 1 |
| Moe, GW | 2 |
| Karlinsky, SJ | 1 |
| Frankel, D | 1 |
| Armstrong, PW | 2 |
| Stockley, IH | 1 |
| Linde, M | 2 |
| Ohnhaus, EE | 3 |
| Kirch, W | 3 |
| Bartorelli, A | 1 |
| Pepi, M | 1 |
| Guazzi, M | 1 |
| Zharov, EI | 1 |
| Sukhorukova, ES | 3 |
| Sedov, VP | 1 |
| Ovcharenko, KI | 2 |
| Broks-Bratkowska, B | 1 |
| Lewis, BS | 2 |
| Shefer, A | 2 |
| Flugelman, MY | 2 |
| Merdler, A | 2 |
| Halon, DA | 2 |
| Hardoff, R | 2 |
| Momma, K | 1 |
| Takao, A | 1 |
| Sivkov, II | 1 |
| Agababian, IR | 1 |
| Abdullaev, NA | 1 |
| Roth, A | 1 |
| Hsueh, W | 1 |
| Freidenberger, L | 1 |
| Núñez Jáuregui, P | 1 |
| Barjon, JN | 1 |
| Rouleau, JL | 1 |
| Bichet, D | 1 |
| Juneau, C | 1 |
| De Champlain, J | 1 |
| Strauer, BE | 1 |
| Artman, M | 1 |
| Graham, TP | 1 |
| Barbieri, L | 1 |
| Mestroni, L | 1 |
| Lefkowitz, CA | 1 |
| Krüger, R | 1 |
| Figulla, HR | 1 |
| Luig, H | 1 |
| Nieschlag, F | 1 |
| Yin, HQ | 1 |
| Chen, RX | 2 |
| Chen, XY | 1 |
| Given, BD | 1 |
| Lee, TH | 1 |
| Stone, PH | 1 |
| Dzau, VJ | 1 |
| Eicher, JC | 1 |
| Morelon, P | 1 |
| Chalopin, JM | 1 |
| Tanter, Y | 1 |
| Louis, P | 1 |
| Rifle, G | 1 |
| Merzon, AK | 1 |
| Donskova, TV | 1 |
| Zolotov, NA | 2 |
| Kolomiets, VV | 2 |
| Merzon, KA | 3 |
| Solov'ev, VV | 2 |
| Salishcheva, LE | 1 |
| Chernikov, VA | 1 |
| Coli, A | 1 |
| Ammirati, A | 1 |
| Dina, MA | 1 |
| Malaia, LT | 1 |
| Savchuk, AM | 1 |
| Packer, M | 1 |
| Lee, WH | 1 |
| Medina, N | 1 |
| Yushak, M | 1 |
| Bernstein, JL | 1 |
| Kessler, PD | 1 |
| Todo, Y | 1 |
| Ohyanagi, M | 1 |
| Fujisue, R | 1 |
| Iwasaki, T | 1 |
| Vlay, SC | 1 |
| Olson, L | 1 |
| Iakovlev, SV | 1 |
| Lazutin, VK | 1 |
| Glezer, MG | 1 |
| Chistova, VS | 1 |
| Sergeeva, EV | 1 |
| Goncharova, LN | 1 |
| Danilova, IV | 1 |
| Baughman, KL | 1 |
| Larach, DR | 1 |
| Zelis, R | 1 |
| Morimoto, Y | 2 |
| Kakuta, Y | 2 |
| Nakano, T | 2 |
| Konishi, T | 2 |
| Takezawa, H | 2 |
| Koyama, T | 1 |
| Kodera, T | 1 |
| Kanamaru, M | 1 |
| Stenzel, J | 1 |
| Dylewicz, P | 1 |
| Hutt, HJ | 1 |
| Santos, SR | 1 |
| Kendall, MJ | 1 |
| Horton, RC | 1 |
| Smith, SR | 1 |
| Makino, M | 1 |
| Umino, M | 1 |
| Nagano, K | 1 |
| Lauterburg, BH | 1 |
| Kiowski, W | 1 |
| Erne, P | 1 |
| Pfisterer, M | 1 |
| Mueller, J | 1 |
| Buehler, FR | 1 |
| Burkart, F | 1 |
| Moldotashev, IK | 1 |
| Noruzbaeva, AM | 1 |
| Tenenbaum, AM | 1 |
| Khosseĭn, A | 1 |
| Ataullakhanova, DM | 1 |
| Almazov, II | 1 |
| Lobova, NM | 1 |
| Ordian, MM | 2 |
| Sobol', IuS | 2 |
| Kassirskiĭ, SG | 2 |
| Green, JA | 1 |
| Nara, AR | 1 |
| Gengo, FM | 1 |
| Maiorov, NI | 1 |
| Mazzola, C | 1 |
| Vaccarella, A | 1 |
| Guffanti, E | 1 |
| Colnago, R | 1 |
| Scarpazza, P | 1 |
| Turri, DR | 1 |
| Fiorella, G | 1 |
| Myrhed, M | 1 |
| Wiholm, BE | 1 |
| Doviner, AD | 1 |
| Kiriaev, AA | 1 |
| Greenbaum, RA | 1 |
| Wan, S | 1 |
| Evans, TR | 1 |
| Ryman, KS | 1 |
| Lystash, J | 1 |
| Stone, G | 1 |
| Sokolov, AM | 1 |
| Koshlia, VI | 2 |
| Drexler, H | 1 |
| Just, H | 1 |
| Nitsch, J | 1 |
| Kuhnen, R | 1 |
| Lüderitz, B | 1 |
| Walsh, RA | 1 |
| At'kov, OIu | 1 |
| Lu, QQ | 1 |
| Winniford, MD | 1 |
| Hillis, LD | 1 |
| Schroeder, JS | 1 |
| Emanuelsson, H | 1 |
| Hjalmarson, A | 1 |
| Holmberg, S | 1 |
| Waagstein, F | 1 |
| Fox, SC | 1 |
| Tweddel, AC | 1 |
| Hutton, I | 1 |
| Urquhart, J | 1 |
| Epstein, SE | 1 |
| Patterson, RE | 1 |
| Fifer, MA | 2 |
| Lorell, BH | 2 |
| Jaski, BE | 1 |
| Barry, WH | 1 |
| Wynne, J | 1 |
| Ren, JH | 1 |
| Ruksin, VV | 1 |
| Miller, AB | 1 |
| Conetta, DA | 1 |
| Bass, TA | 1 |
| Gertz, MA | 2 |
| Skinner, M | 2 |
| Connors, LH | 1 |
| Falk, RH | 2 |
| Cohen, AS | 2 |
| Kyle, RA | 2 |
| Kimchi, A | 1 |
| Charuzi, Y | 1 |
| Shell, W | 1 |
| Murata, GH | 1 |
| McKay, C | 1 |
| Rahimtoola, S | 1 |
| Dickinson, DF | 1 |
| Wilson, N | 1 |
| Curry, P | 1 |
| Nakamura, Y | 1 |
| Ikeda, T | 1 |
| Takata, S | 1 |
| Yamamoto, M | 1 |
| Kitamura, T | 1 |
| Hattori, N | 1 |
| Cohan, JA | 1 |
| Checcio, LM | 1 |
| Arriagada, D | 1 |
| Marchant, E | 1 |
| Chamorro, G | 1 |
| Rodríguez, JA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Alternative in Beta Blocker Intolerance; the ABBI Trial[NCT00893984] | Phase 4 | 6 participants (Actual) | Interventional | 2009-05-31 | Terminated (stopped due to Lack of patient recruitment) | ||
| Regional and Systemic Hemodynamic Effects of a Long-term Administration of Amlodipine in Patients With Chronic Heart Failure Treated With a Combination of Enalapril, Furosemide and Digoxin[NCT00151619] | Phase 2 | 7 participants (Actual) | Interventional | 1999-02-10 | Terminated | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00893984)
Timeframe: 30 Days
| Intervention | Participants (Count of Participants) |
|---|---|
| Nebivolol | 0 |
(NCT00893984)
Timeframe: 30 Days
| Intervention | Participants (Count of Participants) |
|---|---|
| Nebivolol | 0 |
Mild symptoms include weight gain, edema, and headaches (NCT00893984)
Timeframe: 30 Days
| Intervention | participants (Number) |
|---|---|
| Nebivolol | 1 |
(NCT00893984)
Timeframe: 30 Days
| Intervention | Participants (Count of Participants) |
|---|---|
| Nebivolol | 0 |
28 reviews available for nifedipine and Heart Failure
| Article | Year |
|---|---|
Focused Update on Pharmacologic Management of Hypertensive Emergencies.
Topics: Administration, Oral; Antihypertensive Agents; Blood Pressure; Brain Ischemia; Emergencies; Enalapri | 2018 |
The ACTION study: nifedipine in patients with symptomatic stable angina and hypertension.
Topics: Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Comorbidity; Cor | 2008 |
The role of the new beta-blockers in treating cardiovascular disease.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Benzopyrans | 2005 |
Angiotensin II-mediated vasoconstriction in chronic congestive heart failure, and response to converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Dipeptides; Enalapril; Enalaprilat; Glomerular Filtration | 1984 |
Clinical value of calcium antagonists in treatment of cardiovascular disorders.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Arrhythmias, Cardiac; Calciu | 1983 |
Clinical applications of slow channel blocking compounds.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Blood Platelets; Blood Vessels; Calcium | 1983 |
Isosorbide dinitrate in clinical practice.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Blood Pressure; Clinical Tri | 1984 |
Mechanism of action of calcium-channel-blocking agents.
Topics: Action Potentials; Angina Pectoris; Arrhythmias, Cardiac; Blood Vessels; Calcium; Calcium Channel Bl | 1982 |
[Use of calcium antagonists in the treatment of cardiac insufficiency].
Topics: Adult; Aged; Calcium Channel Blockers; Diltiazem; Heart Failure; Humans; Middle Aged; Nifedipine; Ve | 1984 |
Nifedipine in heart failure.
Topics: Animals; Dogs; Guinea Pigs; Heart Failure; Heart Rate; Heart Ventricles; Humans; Myocardial Contract | 1984 |
Vascular versus myocardial effects of calcium antagonists.
Topics: Amlodipine; Animals; Dogs; Felodipine; Heart Failure; Hemodynamics; Humans; Muscle, Smooth, Vascular | 1994 |
Calcium channel blockers in heart failure.
Topics: Calcium Channel Blockers; Diltiazem; Heart Failure; Hemodynamics; Humans; Nifedipine; Verapamil | 1993 |
Vascular selective calcium entry blockers in the treatment of cardiovascular disorders: focus on felodipine.
Topics: Amlodipine; Calcium Channel Blockers; Coronary Disease; Felodipine; Heart Failure; Hemodynamics; Hum | 1995 |
Long-term ventricular wall actuation: can and should it be systematically explored?
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Heart Failure; Heart Valves | 1996 |
Calcium channel blockers in left ventricular dysfunction or congestive heart failure.
Topics: Amlodipine; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Felodipine; Heart Failure | 1997 |
Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients.
Topics: Amlodipine; Calcium Channel Blockers; Cause of Death; Cerebrovascular Disorders; Clinical Trials as | 1998 |
Pharmacodynamics of nilvadipine, a new dihydropyridine-type calcium antagonist.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Calcium Channels; Heart; | 1992 |
Relationship between the inhibition of receptor-induced increase in cytosolic free calcium concentration and the vasodilator effects of nitrates in patients with congestive heart failure.
Topics: Adult; Blood Platelets; Calcium; Heart Failure; Humans; Isosorbide Dinitrate; Middle Aged; Nifedipin | 1990 |
[Treatment of heart failure with calcium antagonists].
Topics: Calcium Channel Blockers; Diltiazem; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Ni | 1990 |
Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.
Topics: Absorption; Adrenergic beta-Antagonists; Angina Pectoris; Animals; Blood Platelets; Calcium Channel | 1985 |
New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1986 |
Calcium channel blockade in heart failure.
Topics: Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Heart; Heart Failure; Hemodyna | 1989 |
[Calcium antagonists in congestive heart failure].
Topics: Calcium Channel Blockers; Cardiomyopathy, Dilated; Diltiazem; Felodipine; Heart Failure; Hemodynamic | 1988 |
Calcium channel blocking agents in congestive heart failure.
Topics: Administration, Oral; Biological Transport; Calcium; Calcium Channel Blockers; Cardiac Output; Cardi | 1986 |
Advances in calcium blocker therapy.
Topics: Arrhythmias, Cardiac; Arteriosclerosis; Asthma; Blood Platelet Disorders; Calcium; Calcium Channel B | 1986 |
Calcium antagonists and chronic cardiac failure.
Topics: Calcium Channel Blockers; Chronic Disease; Diltiazem; Heart Failure; Humans; Nifedipine; Verapamil | 1986 |
Calcium antagonists in patients with cardiovascular disease. Current perspectives.
Topics: Angina Pectoris; Angina Pectoris, Variant; Atrial Fibrillation; Atrial Flutter; Benzazepines; Cardio | 1985 |
Combination therapy with isosorbide dinitrate: current status and the future.
Topics: Angina Pectoris; Coronary Vasospasm; Diltiazem; Drug Therapy, Combination; Esophageal Achalasia; Exe | 1985 |
26 trials available for nifedipine and Heart Failure
| Article | Year |
|---|---|
The development of heart failure in patients with stable angina pectoris.
Topics: Aged; Angina Pectoris; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardi | 2007 |
Predictive value of local and core laboratory echocardiographic assessment of cardiac function in patients with chronic stable angina: The ACTION study.
Topics: Angina Pectoris; Biomarkers; Calcium Channel Blockers; Chronic Disease; Coronary Artery Disease; Cor | 2007 |
Isosorbide dinitrate in clinical practice.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Blood Pressure; Clinical Tri | 1984 |
Disparate unloading efficacy of the calcium channel blockers, verapamil and nifedipine, on the failing hypertensive left ventricle.
Topics: Cardiac Output; Clinical Trials as Topic; Echocardiography; Female; Heart Failure; Heart Ventricles; | 1984 |
[Pharmacokinetics and cardiac effect of beta-acetyldigoxin and digitoxin in combination therapy with nifedipine].
Topics: Acetyldigitoxins; Aged; Digitoxin; Drug Therapy, Combination; Electrocardiography; Female; Heart Con | 1984 |
Long-term clinical effect of nilvadipine in patients with chronic heart failure: a double-blind placebo-controlled study.
Topics: Calcium Channel Blockers; Double-Blind Method; Exercise Tolerance; Female; Heart Failure; Hemodynami | 1994 |
Nifedipine does not improve survival in AMI patients without heart failure. The SPRINT Study Group.
Topics: Heart Failure; Humans; Myocardial Infarction; Nifedipine; Survival Analysis | 1993 |
Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
Topics: Administration, Inhalation; Adult; Aged; Atrial Function, Right; Calcium Channel Blockers; Drug Ther | 1999 |
Intravenous L-arginine reduces VE/VCO2 slope acutely in patients with severe chronic heart failure.
Topics: Arginine; Blood Pressure; Breath Tests; Carbon Dioxide; Chronic Disease; Cross-Over Studies; Exercis | 1999 |
[Effects of peripheral vasodilators on arrhythmia in patients with chronic coronary insufficiency].
Topics: Arrhythmias, Cardiac; Captopril; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Isos | 1992 |
[Results of conventional treatment of severe congestive heart failure with vasodilators].
Topics: Adult; Aged; Captopril; Digoxin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fu | 1992 |
Hemodynamic comparison of combined therapy by nitroglycerin tape and ibopamine with combination of nitroglycerin tape and nifedipine.
Topics: Administration, Cutaneous; Administration, Oral; Cardiac Complexes, Premature; Cardiotonic Agents; D | 1990 |
[Differential use of peripheral vasodilators in the treatment of chronic circulatory failure in patients with mitral valve insufficiency].
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Hydralazine; | 1990 |
[Effect of vasodilator agents on the character and incidence of cardiac arrhythmia in chronic heart failure].
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Atrial Fibrillation; Captopril; Cardiac Output | 1990 |
[The effect of calcium antagonists on the hemodynamic function in patients with heart failure].
Topics: Calcium Channel Blockers; Cardiography, Impedance; Coronary Disease; Echocardiography; Heart Failure | 1990 |
A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure.
Topics: Adolescent; Adult; Aged; Blood Pressure; Chronic Disease; Diuretics; Double-Blind Method; Drug Combi | 1990 |
Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.
Topics: Absorption; Adrenergic beta-Antagonists; Angina Pectoris; Animals; Blood Platelets; Calcium Channel | 1985 |
[Mechano- and impedance cardiography parameters in patients with heart failure in administration of a calcium antagonist. The significance of the Heather index].
Topics: Aged; Cardiac Output; Cardiography, Impedance; Clinical Trials as Topic; Double-Blind Method; Electr | 1989 |
Calcium channel blockade in heart failure.
Topics: Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Heart; Heart Failure; Hemodyna | 1989 |
[Effect of the calcium antagonist nifangin on hemodynamics in patients with congestive heart failure].
Topics: Adult; Aged; Calcium Channel Blockers; Clinical Trials as Topic; Female; Heart Failure; Hemodynamics | 1989 |
[Evaluation of the effect of nifedipine in patients with chronic congestive heart failure].
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Digoxin; Diuresis; Female; Furosemide; Heart | 1989 |
Neurohumoral consequences of vasodilator therapy with hydralazine and nifedipine in severe congestive heart failure.
Topics: Adult; Aged; Aldosterone; Catecholamines; Drug Therapy, Combination; Epinephrine; Female; Heart Fail | 1986 |
[Clinical and hemodynamic effects of nisoldipine and captopril in heart failure: a double-blind comparative study of long and short-term effects].
Topics: Adult; Aged; Captopril; Clinical Trials as Topic; Double-Blind Method; Female; Heart Failure; Hemody | 1987 |
The "Heather Index" in impedance cardiography.
Topics: Cardiography, Impedance; Clinical Trials as Topic; Double-Blind Method; Heart Failure; Humans; Middl | 1988 |
Influence of nisoldipine on haemodynamic effects and plasma levels of digoxin.
Topics: Adult; Aged; Calcium Channel Blockers; Clinical Trials as Topic; Digoxin; Double-Blind Method; Femal | 1986 |
Acute haemodynamic effects of felodipine in congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Felodipine; Female; Heart Fai | 1985 |
171 other studies available for nifedipine and Heart Failure
| Article | Year |
|---|---|
Synthesis and Biological Activity of the Pyridine-hexacyclic-steroid Derivative on a Heart Failure Model.
Topics: Heart Failure; Humans; Nifedipine; Steroids | 2022 |
Comparative efficacy of generic nifedipine versus brand-name amlodipine for hypertension management in Taiwan.
Topics: Amlodipine; Calcium Channel Blockers; Drugs, Generic; Heart Failure; Humans; Hypertension; Ischemic | 2022 |
Evaluation of Biological Activity of a Diazocine Derivative against Heart Failure Using an Ischemia-Reperfusion Injury Model.
Topics: Animals; Heart; Heart Failure; Infarction; Myocardial Reperfusion Injury; Nifedipine; Rats | 2022 |
A case study of applying text analysis to identify possible adverse drug interactions: The case of Adalat (Nifedipine).
Topics: Female; Heart Failure; Humans; Israel; Male; Nifedipine; Pharmaceutical Preparations | 2020 |
Cardioprotective Effects of Mebudipine in a Rat Model of Doxorubicin-Induced Heart Failure.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Disease Models, Animal; Doxorubicin; Heart; Heart | 2021 |
Exclusion of alternative exon 33 of Ca
Topics: Action Potentials; Alternative Splicing; Animals; Calcium Channel Blockers; Calcium Channels, L-Type | 2017 |
Effects of late-onset and long-term captopril and nifedipine treatment in aged spontaneously hypertensive rats: Echocardiographic studies.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Captopril; Drug Evaluati | 2015 |
Successful Treatment with an Antihypertensive Drug Regimen Including Eplerenone in a Patient with Malignant Phase Hypertension with Renal Failure.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cal | 2015 |
Effect of contraindicated drugs for heart failure on hospitalization among seniors with heart failure: A nested case-control study.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Calcium Channel Blockers; Case-Con | 2017 |
A comparison of the effects of commercially available hawthorn preparations on calcium transients of isolated cardiomyocytes.
Topics: Animals; Calcium; Calcium Channel Blockers; Cardiotonic Agents; Crataegus; Heart Failure; Herb-Drug | 2008 |
Pharmacoepidemiologic detection of calcium channel blocker-induced change on digoxin clearance using multiple trough screen analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Calcium Channel Blockers; Creatinine; Digoxi | 2002 |
Adverse events associated with aggressive treatment of increased blood pressure.
Topics: Administration, Oral; Aged; Aged, 80 and over; Brain Ischemia; Capsules; Chronic Disease; Female; He | 2004 |
Clinical trials update from the European Society of Cardiology: SENIORS, ACES, PROVE-IT, ACTION, and the HF-ACTION trial.
Topics: Adrenergic beta-Antagonists; Antibiotic Prophylaxis; Benzopyrans; Ethanolamines; Heart Failure; Huma | 2004 |
Nifedipine enhances the cardioprotective effect of an angiotensin-II receptor blocker in an experimental animal model of heart failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Body Weight; C | 2005 |
Delayed clinical decompensation and death after pediatric nifedipine overdose.
Topics: Calcium Channel Blockers; Child, Preschool; Drug Overdose; Fatal Outcome; Heart Failure; Humans; Mal | 2007 |
Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.
Topics: Adult; Aged; Calcium Channel Blockers; Cardiac Output; Chronic Disease; Female; Forearm; Heart Failu | 1984 |
Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arterioles; Captopril; Enalapril; | 1983 |
Drugs and the heart. III. Calcium antagonists.
Topics: Angina Pectoris; Aniline Compounds; Arrhythmias, Cardiac; Calcium; Cardiomegaly; Diuretics; Heart Di | 1980 |
Nifedipine and beta-blocker drugs.
Topics: Adrenergic beta-Antagonists; Aged; Drug Interactions; Drug Therapy, Combination; Heart Failure; Huma | 1980 |
Nifedipine and beta-blockade as a cause of cardiac failure.
Topics: Adrenergic beta-Antagonists; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Nifedi | 1982 |
[Nifedipine in the therapy of myocardial infarct in patients over 70].
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Digitalis Glycosides; Female; Heart Block | 1982 |
Nifedipine therapy in angina pectoris: evaluation of safety and side effects.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Calcium Channel | 1982 |
[Hemodynamic effects of nifedipine in chronic cardiac failure].
Topics: Heart Failure; Hemodynamics; Humans; Nifedipine; Pyridines | 1983 |
Effects of vasodilator treatment with felodipine on haemodynamic responses to treadmill exercise in congestive heart failure.
Topics: Adult; Aged; Antihypertensive Agents; Drug Evaluation; Felodipine; Female; Heart Failure; Heart Func | 1984 |
Restoration of normal reflex responses to orthostatic stress during felodipine therapy in congestive heart failure.
Topics: Adult; Aged; Felodipine; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nife | 1984 |
Beneficial effects of nifedipine on rest and exercise myocardial energetics in patients with congestive heart failure.
Topics: Adult; Cardiac Catheterization; Cardiomyopathy, Dilated; Coronary Circulation; Female; Heart; Heart | 1984 |
Evaluation of the effect of nifedipine in men after myocardial infarction.
Topics: Adult; Cardiac Catheterization; Cardiac Output; Exercise Test; Heart Failure; Hemodynamics; Humans; | 1984 |
[The hypertensive crisis].
Topics: Acute Disease; Calcium Channel Blockers; Clonidine; Coronary Disease; Diazoxide; Dihydralazine; Dilt | 1984 |
Renal hemodynamic effects of vasodilation with nifedipine and hydralazine in patients with heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Glomerular Filtration Rate; Heart Failure; Humans; Hydr | 1984 |
Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Exercise Test; Extremities; Female; Heart Failure; Hear | 1984 |
Intravenous nicardipine in patients with chronic heart failure: a nuclear stethoscope study.
Topics: Adult; Aged; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Heart Failure; Heart Rate; He | 1984 |
Acute hemodynamic effect of oral nifedipine in severe chronic congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Failure; Heart Rate; Hemodynamics; Humans | 1983 |
Evaluation of calcium-mediated vasoconstriction in chronic congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Calcium; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nifedi | 1983 |
The search for a digitalis substitute II milrinone (Win 47203). Its action on the heart-lung preparation of the dog.
Topics: Animals; Cardiotonic Agents; Dinitrophenols; Dogs; Heart; Heart Failure; Milrinone; Nifedipine; Papa | 1983 |
[Increased digitalis-like activity in combined administration of calcium antagonists and digitalis preparations].
Topics: Aged; Digoxin; Drug Interactions; Drug Therapy, Combination; Heart Failure; Humans; Medigoxin; Middl | 1983 |
[Effects of calcium antagonists on mean circulatory pressure].
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Diltiazem; Dogs; Heart Failure; H | 1983 |
Hemodynamic effects of nisoldipine in chronic congestive heart failure.
Topics: Adult; Calcium Channel Blockers; Heart Failure; Hemodynamics; Humans; Middle Aged; Nifedipine; Nisol | 1983 |
Acute haemodynamic and metabolic effects of felodipine in congestive heart failure.
Topics: Adult; Aged; Fatty Acids, Nonesterified; Felodipine; Glucose; Heart Failure; Hemodynamics; Humans; L | 1984 |
Nifedipine in hypertension and heart failure.
Topics: Adult; Aged; Blood Pressure; Delayed-Action Preparations; Drug Therapy, Combination; Female; Heart F | 1984 |
[Erb's muscular dystrophy and congestive myocardiopathy. Description of a case with a whoop due to tricuspid insufficiency].
Topics: Adult; Cardiomyopathy, Dilated; Heart Auscultation; Heart Failure; Heart Murmurs; Humans; Male; Musc | 1984 |
Beneficial hemodynamic effects of intravenous and oral diltiazem in severe congestive heart failure.
Topics: Administration, Oral; Adult; Benzazepines; Diltiazem; Female; Heart Failure; Heart Rate; Hemodynamic | 1984 |
Comparison of hemodynamic responses to nifedipine and nitroprusside in severe chronic congestive heart failure.
Topics: Administration, Oral; Aged; Chronic Disease; Female; Ferricyanides; Heart; Heart Failure; Hemodynami | 1984 |
Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Hydralazine; M | 1984 |
Calcium-channel blockers for chronic congestive heart failure.
Topics: Heart Failure; Hemodynamics; Humans; Nifedipine | 1984 |
Nifedipine and beta-blockade as a cause of cardiac failure.
Topics: Atenolol; Drug Therapy, Combination; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction | 1982 |
Calcium antagonists in heart failure.
Topics: Aortic Valve Insufficiency; Calcium Channel Blockers; Coronary Disease; Diltiazem; Heart Failure; He | 1983 |
Acute hemodynamic effects of combined therapy with digoxin and nifedipine in patients with chronic heart failure.
Topics: Aged; Blood Pressure; Cardiac Output; Digoxin; Drug Therapy, Combination; Female; Heart Failure; Hem | 1983 |
The effects of calcium channel blocking agents on cardiovascular function.
Topics: Angina Pectoris; Animals; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Coronary Disease | 1982 |
Use of nifedipine in older patients and patients with congestive heart failure.
Topics: Age Factors; Aged; Angina Pectoris; Female; Heart Failure; Humans; Male; Middle Aged; Nifedipine; Py | 1982 |
Influence of nifedipine on left ventricular dysfunction at rest and during exercise.
Topics: Coronary Disease; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; | 1982 |
[Use of nifedipine in chronic refractory cardiac insufficiency secondary to left ventricular dysfunction].
Topics: Exercise Test; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Nifedipine; Pyridines | 1982 |
Primary pulmonary hypertension: effects of nifedipine.
Topics: Adult; Female; Heart Failure; Humans; Hypertension, Pulmonary; Nifedipine; Pyridines | 1981 |
Influence of nifedipine left ventricular systolic and diastolic function. Relationships to manifestations of ischemia and congestive failure.
Topics: Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Coronary Disease; Coronar | 1981 |
[Hemodynamic effects of combined isosorbide dinitrate-nifedipine therapy in congestive heart failure (author's transl)].
Topics: Aged; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; | 1981 |
Slow-channel calcium blockers in heart failure: a plea for cautious optimism.
Topics: Calcium Channel Blockers; Heart Failure; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nifedi | 1981 |
Comparison of acute haemodynamic effects of nifedipine and isosorbide dinitrate in patients with heart failure following acute myocardial infarction.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Failure; Heart Rate; Hemodynamics; Humans | 1981 |
Afterload reducing agents in congestive cardiomyopathy; a study with a calcium antagonist drug: nifedipine.
Topics: Blood Pressure; Cardiac Output; Heart Failure; Humans; Nifedipine; Pyridines; Vascular Resistance | 1980 |
[The hemodynamic effects of nifedipine in congestive cardiomyopathy (author's transl)].
Topics: Adolescent; Adult; Cardiomyopathies; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; | 1980 |
Haemodynamic effects of nifedipine in heart failure.
Topics: Adult; Aged; Cardiac Catheterization; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Midd | 1980 |
Hemodynamic effects of nifedipine in congestive heart failure.
Topics: Adult; Cardiac Output; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Hydralazine; Male; M | 1980 |
Unpredictable response to nifedipine in severe cardiac failure.
Topics: Heart Failure; Hemodynamics; Humans; Hypotension; Male; Middle Aged; Nifedipine; Pyridines | 1980 |
[Comparative analysis of several treatment methods for severe congestive heart failure].
Topics: Adult; Aged; Aged, 80 and over; Captopril; Digoxin; Drugs, Chinese Herbal; Female; Heart Failure; Hu | 1993 |
Effects of vasodilators on pulmonary venous and mitral flow velocity patterns in patients with congestive heart failure.
Topics: Adult; Aged; Blood Flow Velocity; Echocardiography, Doppler; Female; Heart Failure; Humans; Isosorbi | 1993 |
ED management of acute congestive heart failure in renal dialysis patients.
Topics: Acute Disease; Administration, Cutaneous; Administration, Oral; Administration, Sublingual; Captopri | 1993 |
The effect of nifedipine on ventriculoarterial coupling in old myocardial infarction.
Topics: Aged; Arteries; Blood Pressure; Female; Heart Failure; Heart Rate; Heart Ventricles; Humans; Male; M | 1996 |
Phaeochromocytoma--a rare cause of hypertension in an 11-year-old girl.
Topics: Adrenal Gland Neoplasms; Antihypertensive Agents; Calcium Channel Blockers; Catecholamines; Child; F | 1996 |
Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure.
Topics: Adrenergic beta-Agonists; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Chan | 1997 |
A cautionary tale.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Calcium Channel Blockers; Ch | 1997 |
Contribution of reverse-mode sodium-calcium exchange to contractions in failing human left ventricular myocytes.
Topics: Calcium; Calcium Channel Blockers; Calcium-Transporting ATPases; Cells, Cultured; Cytosol; Enzyme In | 1998 |
Regional expression and functional characterization of the L-type Ca2+-channel in myocardium from patients with end-stage heart failure and in non-failing human hearts.
Topics: Adolescent; Adult; Aged; Binding Sites; Blotting, Northern; Blotting, Western; Calcium; Calcium Chan | 1999 |
Mortality in the Jerusalem 70-year-olds longitudinal study: does nifedipine have a role?
Topics: Aged; Coronary Disease; Creatinine; Diuretics; Female; Heart Failure; Humans; Hypertension; Israel; | 1999 |
Chronic hypertension with subsequent congestive heart failure in a western lowland gorilla (Gorilla gorilla gorilla).
Topics: Animals; Animals, Zoo; Antihypertensive Agents; Ape Diseases; Blood Pressure Determination; Chronic | 1999 |
[Sublingual captopril: indications and advantages?].
Topics: Administration, Oral; Administration, Sublingual; Adrenergic alpha-Antagonists; Angiotensin-Converti | 2000 |
Enhanced Ca2+-induced contractions and attenuated alpha-adrenoceptor responses in resistance arteries from rats with congestive heart failure.
Topics: Adrenergic alpha-Antagonists; Animals; Calcium; Heart Failure; Male; Mesenteric Arteries; Muscle, Sm | 2001 |
Enhancement of Rho/Rho-kinase system in regulation of vascular smooth muscle contraction in tachycardia-induced heart failure.
Topics: Amides; Analysis of Variance; Angiotensin II; Animals; Calcium; Calcium Channel Blockers; Cardiac Pa | 2001 |
Gadolinium prevents stretch-mediated contractile dysfunction in isolated papillary muscles.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Dihydropyridines; Gadolinium; Guinea Pi | 2001 |
Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure.
Topics: Angiotensin II; Animals; Apoptosis; Biphenyl Compounds; Calcium Channel Blockers; Drug Evaluation, P | 2001 |
Comparison of amlodipine or nifedipine treatment with developing congestive heart failure: effects on myocyte contractility.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Disease Models, Animal; Heart Failure; Male; Microsco | 2001 |
L-type Ca(2+) currents overlapping threshold Na(+) currents: could they be responsible for the "slip-mode" phenomenon in cardiac myocytes?
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2002 |
Hypercalcemic effect of nifedipine treatment in man.
Topics: Aged; Calcium; Creatinine; Cyclic AMP; Female; Heart Failure; Humans; Hypercalcemia; Male; Middle Ag | 1977 |
Hemodynamic effects of sublingual nifedipine in congestive heart failure.
Topics: Administration, Oral; Aged; Blood Pressure; Calcium; Cardiac Output; Female; Heart Failure; Hemodyna | 1979 |
[Effects of calcium antagonists on left ventricular systolic time intervals in patients with artificial pacemakers].
Topics: Aged; Arrhythmias, Cardiac; Calcium; Cardiac Pacing, Artificial; Female; Heart Block; Heart Failure; | 1979 |
[The effect of nifedipine on the pulmonary artery pressure in patients with coronary heart disease (author's transl)].
Topics: Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Dyspnea; Female; Heart Failure; Humans; Mal | 1978 |
Pharmacological preservation of the ischemic heart.
Topics: Animals; Calcium; Calcium Chloride; Cardiopulmonary Bypass; Coronary Disease; Dogs; Female; Heart Fa | 1977 |
[Heart failure in acute myocardial infarction: comparing infusions of nifedipine and nitroglycerin].
Topics: Adult; Aged; Aged, 80 and over; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; | 1992 |
Differences in blood pressure regulation of congestive heart failure, before and after treatment, correlate with changes in the circulating pattern of atrial natriuretic peptide.
Topics: Aged; Atrial Natriuretic Factor; Blood Pressure; Cardiotonic Agents; Digoxin; Drug Therapy, Combinat | 1992 |
Calcium antagonist caution.
Topics: Calcium Channel Blockers; Contraindications; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitra | 1991 |
Acute hemodynamic effects of nilvadipine, a new calcium channel blocker, in patients with congestive heart failure.
Topics: Aged; Aged, 80 and over; Blood Pressure; Calcium Channel Blockers; Female; Heart Failure; Hemodynami | 1990 |
Hemodynamic effects of the vascular selective calcium antagonist felodipine in patients with impaired left ventricular function.
Topics: Coronary Disease; Felodipine; Heart Failure; Hemodynamics; Humans; Hypertension; Myocardial Contract | 1992 |
All calcium channel blockers are not alike.
Topics: Amlodipine; Calcium Channel Blockers; Diltiazem; Felodipine; Heart Failure; Humans; Nifedipine | 1991 |
Haemodynamic effects of slow-release nifedipine in severe congestive heart failure due to ischaemic heart disease.
Topics: Aged; Coronary Disease; Delayed-Action Preparations; Exercise Test; Female; Heart Failure; Hemodynam | 1990 |
[Use of peripheral vasodilator agents corbaton and corinfar combined with digoxin in patients with congestive heart failure of rheumatic etiology].
Topics: Adult; Digoxin; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle | 1990 |
Nifedipine pharmacodynamics and pharmacokinetics in treatment of congestive heart failure.
Topics: Adolescent; Adult; Aged; Coronary Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Middle | 1990 |
[Hemodynamic responses to sublingual nifedipine during exercise and recovery in congestive heart failure].
Topics: Administration, Sublingual; Adult; Cardiomyopathy, Dilated; Exercise Test; Female; Heart Failure; He | 1990 |
Different negative inotropic activity of Ca2(+)-antagonists in human myocardial tissue.
Topics: Calcium Channel Blockers; Depression, Chemical; Diltiazem; Heart Atria; Heart Failure; Heart Transpl | 1990 |
[Evaluation of the effectiveness of calcium antagonists combined with digoxin and furosemide in hypertension complicated by circulatory insufficiency in elderly patients].
Topics: Aged; Digoxin; Drug Therapy, Combination; Furosemide; Heart Failure; Hemodynamics; Humans; Hypertens | 1990 |
Long-term effect of isosorbide dinitrate and nifedipine, singly and in association, in patients with chronic heart failure.
Topics: Blood Pressure; Cardiac Output; Chronic Disease; Drug Therapy, Combination; Heart Failure; Hemodynam | 1990 |
[Nifedipine and molsidomine treatment of circulatory insufficiency in elderly patients with hypertension].
Topics: Age Factors; Aged; Aged, 80 and over; Cardiac Glycosides; Diuretics; Drug Evaluation; Drug Therapy, | 1990 |
Severe pulmonary hypertension in a patient with Whipple's disease.
Topics: Drug Combinations; Furosemide; Heart Failure; Heart Murmurs; Humans; Hypertension, Pulmonary; Male; | 1985 |
[Correction of metabolic disorders of the myocardium in acute myocardial infarct as an important factor in preventing the development of circulatory insufficiency].
Topics: Animals; Aprotinin; Ascorbic Acid; Drug Therapy, Combination; Glutamates; Glutamic Acid; Heart Failu | 1985 |
Enalapril in experimental hypertension and acute heart failure: comparison with calcium channel blockers.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; D | 1986 |
Nifedipine following acute myocardial infarction--dependence of response on baseline haemodynamic status.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Electrocardiography; Heart Failure; Heart Rate; Hemodyn | 1987 |
Intravenous nisoldipine in severe congestive heart failure.
Topics: Adult; Aged; Calcium Channel Blockers; Dose-Response Relationship, Drug; Female; Heart Failure; Hemo | 1988 |
Are beta blockers and nifedipine safe?
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Heart Failure; Humans; Nifedipine | 1989 |
[Pharmacodynamics and pharmacokinetics of nifedipine in patients with congestive heart failure].
Topics: Adolescent; Adult; Aged; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nifedipine; | 1989 |
[The efficacy of calcium antagonists in circulatory failure in elderly patients with hypertension].
Topics: Aged; Calcium Channel Blockers; Digoxin; Dose-Response Relationship, Drug; Drug Evaluation; Drug The | 1989 |
Effect of the second-generation calcium channel blocking drug nisoldipine on diastolic left ventricular dysfunction in heart failure.
Topics: Aged; Calcium Channel Blockers; Cardiac Output; Female; Heart; Heart Failure; Humans; Male; Middle A | 1989 |
Fetal cardiovascular effects of nifedipine in rats.
Topics: Animals; Cardiovascular System; Dose-Response Relationship, Drug; Female; Fetus; Heart Failure; Nife | 1989 |
[Acute nifedipine (corinfar) test in congestive heart failure].
Topics: Adult; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Models, Biological; Nifedipin | 1989 |
[Use of nifedipine in patients with advanced arteriosclerotic cardiopathy].
Topics: Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Cardiac Output, Low; Coronary Artery Diseas | 1986 |
Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure.
Topics: Body Water; Calcium Channel Blockers; Heart Failure; Hemodynamics; Humans; Kidney; Male; Middle Aged | 1987 |
[Progression and regression of heart hypertrophy in arterial hypertension: pathophysiology and clinical aspects].
Topics: Blood Pressure; Cardiac Volume; Cardiomegaly; Cardiomyopathy, Hypertrophic; Clonidine; Coronary Circ | 1985 |
Guidelines for vasodilator therapy of congestive heart failure in infants and children.
Topics: Captopril; Child; Child, Preschool; Enalapril; Heart Diseases; Heart Failure; Heart Ventricles; Hemo | 1987 |
A comparative evaluation of hemodynamic and neurohumoral effects of nitroglycerin and nifedipine in congestive heart failure.
Topics: Aged; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nifedipine; Nitroglycerin; Ren | 1987 |
[Problems in acute therapy of coronary heart disease using drugs that reduce preload and afterload].
Topics: Coronary Disease; Heart Failure; Hemodynamics; Humans; Hypertension; Molsidomine; Nifedipine; Nitrog | 1987 |
Acute hemodynamic effect and mechanism of nifedipine on severe congestive heart failure.
Topics: Adult; Aged; Catecholamines; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nifedip | 1988 |
Nifedipine in severely hypertensive patients with congestive heart failure and preserved ventricular systolic function.
Topics: Aged; Cardiomegaly; Electrocardiography; Female; Heart Failure; Heart Ventricles; Humans; Hypertensi | 1985 |
Acute renal failure during nifedipine therapy in a patient with congestive heart failure.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Heart Failure; Humans; Male; Nifedipine; Renal Dialysi | 1988 |
[Effect of nifedipine on renal activity].
Topics: Diuresis; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Nifedipine; Water-Electrolyte B | 1988 |
[Relation between hemodynamic reactions to corinfar and the status of peripheral circulation in middle-aged and elderly patients with ischemic heart disease and chronic heart failure].
Topics: Age Factors; Aged; Chronic Disease; Coronary Disease; Female; Heart Failure; Hemodynamics; Humans; L | 1988 |
Unexplained plexogenic pulmonary arteriopathy: an unusual rapidly progressive case in childhood.
Topics: Child, Preschool; Female; Fibromuscular Dysplasia; Heart Failure; Humans; Hypertension, Pulmonary; M | 1988 |
[New developments in the treatment of chronic circulatory insufficiency].
Topics: Captopril; Chronic Disease; Heart Failure; Humans; Nifedipine | 1987 |
Prognostic importance of the immediate hemodynamic response to nifedipine in patients with severe left ventricular dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Cardiac Output; Chronic Disease; Female; Follow-Up S | 1987 |
Radionuclear measurement of peripheral hemodynamics in selection of vasodilators for treatment of heart failure.
Topics: Aged; Arm; Blood Flow Velocity; Blood Volume; Female; Heart Failure; Humans; Isosorbide Dinitrate; M | 1988 |
Improvement in NYHA functional class 4 congestive heart failure patients with nifedipine: a hemodynamic evaluation.
Topics: Administration, Oral; Administration, Sublingual; Female; Follow-Up Studies; Heart Failure; Hemodyna | 1988 |
Effect of the second-generation calcium channel blocker nisoldipine on left ventricular contractility in cardiac failure.
Topics: Aged; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Cardiac Volume; Heart Failure; Heart | 1988 |
[Use of nifedipine for treating heart failure in the subacute period of myocardial infarct in patients over 60].
Topics: Aged; Aged, 80 and over; Drug Evaluation; Female; Heart Failure; Hemodynamics; Humans; Male; Middle | 1987 |
[Use of korinfar in the early stages of heart failure in ischemic heart disease].
Topics: Adult; Coronary Disease; Drug Evaluation; Heart Failure; Humans; Male; Middle Aged; Myocardial Contr | 1987 |
[Acute effects of nifedipine in severe heart failure--hemodynamics, plasma catecholamine levels, renin activity, metabolism and blood gas data].
Topics: Aged; Catecholamines; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nifedipine; Ox | 1986 |
[Effects of sublingual nifedipine on hemodynamic and metabolic responses to exercise (Ergometer, 25W, 5 min.) in patients with severe congestive heart failure].
Topics: Aged; Drug Evaluation; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nifedipine; P | 1987 |
[Clinical pharmacology of calcium antagonists].
Topics: Aging; Arrhythmias, Cardiac; Biological Availability; Calcium Channel Blockers; Diltiazem; Drug Inte | 1987 |
Arterial vasodilator, systemic and coronary hemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathy.
Topics: Aged; Calcium Channel Blockers; Cardiomyopathy, Dilated; Coronary Circulation; Forearm; Heart Failur | 1987 |
[The use of corinfar in combined treatment of congestive heart failure at high altitude].
Topics: Adult; Aged; Altitude; Drug Therapy, Combination; Echocardiography; Female; Heart Failure; Hemodynam | 1987 |
[Changes in regional hemodynamics and tissue oxygenation in heart failure patients as affected by nifedipine (corinfar)].
Topics: Adult; Female; Forearm; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nifedipine; Oxygen C | 1987 |
[Effect of peripheral vasodilators on pulmonary respiratory function and the indices of bicycle spiroergometry in heart failure patients].
Topics: Adolescent; Adult; Delayed-Action Preparations; Drug Evaluation; Exercise Test; Female; Heart Failur | 1987 |
Characterization of the dose-concentration-dependent hemodynamic effects of nifedipine in heart failure.
Topics: Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Middle Aged; Nifedipine | 1987 |
[Effect of corinfar on serum digoxin levels in patients with chronic cardiac insufficiency].
Topics: Aged; Calcium Channel Blockers; Chronic Disease; Digoxin; Drug Therapy, Combination; Heart Failure; | 1987 |
Effects of nicardipine and nifedipine in chronic heart failure: a non invasive study.
Topics: Aged; Chronic Disease; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1987 |
Nifedipine--a survey of adverse effects. Four years' reporting in Sweden.
Topics: Adult; Aged; Angina Pectoris; Confusion; Erythema; Female; Headache; Heart Failure; Humans; Male; Mi | 1986 |
Acute and chronic effects of nicardipine on systolic and diastolic left ventricular performance in patients with heart failure: a pilot study.
Topics: Administration, Oral; Adult; Aged; Calcium Channel Blockers; Cardiac Output; Dose-Response Relations | 1986 |
[Hemodynamic effect of verapamil and nifedipine in chronic heart failure].
Topics: Calcium; Chronic Disease; Drug Evaluation; Female; Heart Failure; Hemodynamics; Humans; Male; Nifedi | 1986 |
The acute haemodynamic effects of nicardipine in patients with chronic left ventricular failure.
Topics: Adult; Aged; Calcium Channel Blockers; Dose-Response Relationship, Drug; Female; Heart Failure; Hemo | 1986 |
Effect of nicardipine on rest and exercise hemodynamics in chronic congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle A | 1986 |
[Effect of molsidomin and nifedipine on tolerance of physical exertion among rheumatic fever patients in the initial stage of heart failure].
Topics: Adult; Female; Heart Failure; Heart Valve Diseases; Humans; Male; Middle Aged; Molsidomine; Nifedipi | 1986 |
[Effect of korvaton and korinfar on systemic circulation in heart failure patients].
Topics: Adult; Blood Circulation; Drug Evaluation; Female; Heart Failure; Hemodynamics; Humans; Male; Middle | 1986 |
[Effect of corinfar on central and regional circulation in patients with heart failure].
Topics: Adult; Cardiography, Impedance; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nife | 1986 |
[Calcium antagonists in heart failure?].
Topics: Calcium Channel Blockers; Cardiac Output; Diltiazem; Heart Failure; Heart Rate; Hemodynamics; Humans | 1986 |
[Increase in liver circulation with nifedipine].
Topics: Adult; Angina Pectoris; Blood Pressure; Cardiac Catheterization; Cardiac Output; Female; Heart Failu | 1986 |
Experience with calcium antagonist drugs in congestive heart failure.
Topics: Calcium Channel Blockers; Heart Failure; Hemodynamics; Humans; Nifedipine; Vasodilation; Vasodilator | 1987 |
[Dynamics of respiratory function and and bicycle ergometry in the treatment of patients with chronic circulatory failure].
Topics: Adult; Calcium Channel Blockers; Digoxin; Drug Therapy, Combination; Exercise Test; Female; Forced E | 1986 |
[Hemodynamic effects of vasodilators in aged patients with heart failure].
Topics: Aged; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nifedipine; Nitroprusside; Phe | 1985 |
Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Drug Therapy, Combination; Heart Failure; Heart Rate; H | 1985 |
Felodipine in ventricular dysfunction.
Topics: Adult; Cardiac Pacing, Artificial; Coronary Circulation; Coronary Disease; Exercise Test; Felodipine | 1986 |
Safety of nifedipine in severe congestive heart failure.
Topics: Heart Failure; Hemodynamics; Humans; Nifedipine; Safety | 1986 |
Effects of nifedipine and diltiazem on plasma levels and renal excretion of beta-acetyldigoxin.
Topics: Acetyldigoxins; Aged; Benzazepines; Digoxin; Diltiazem; Drug Therapy, Combination; Female; Heart Fai | 1985 |
Comparative effects of calcium-channel blocking agents on left ventricular function during acute ischemia in dogs with and without congestive heart failure.
Topics: Animals; Arterial Occlusive Diseases; Calcium Channel Blockers; Coronary Circulation; Coronary Disea | 1985 |
Inotropic, vascular and neuroendocrine effects of nifedipine in heart failure: comparison with nitroprusside.
Topics: Adult; Aged; Blood Pressure; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Male; Middl | 1985 |
Calcium channel blockers in congestive heart failure: theoretic considerations and clinical experience.
Topics: Calcium; Calcium Channel Blockers; Heart Failure; Hemodynamics; Humans; Muscle, Smooth, Vascular; My | 1985 |
Postural influences on the hemodynamic responses to vasodilating drugs in congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Clonidine; Female; Heart Failure; Heart Rate; Hemodynam | 1985 |
Studies with felodipine in congestive heart failure.
Topics: Aged; Anti-Arrhythmia Agents; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Ech | 1985 |
[Peripheral vasodilator in cardiac insufficiency in the acute period of myocardial infarction].
Topics: Cardiomyopathy, Dilated; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Hydralazine | 1985 |
Sublingual nifedipine: acute effects in severe chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy.
Topics: Administration, Oral; Adult; Aged; Cardiac Output; Cardiomyopathy, Dilated; Chronic Disease; Dose-Re | 1985 |
Selective binding of nifedipine to amyloid fibrils.
Topics: Amyloidosis; Heart Failure; Humans; In Vitro Techniques; Nifedipine; Spleen | 1985 |
Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents.
Topics: Amyloidosis; Calcium Channel Blockers; Heart Failure; Humans; Male; Middle Aged; Nifedipine | 1985 |
Salutary hemodynamic and sustained clinical beneficial effects of nisoldipine, a new calcium channel blocker, in patients with recurrent ischemia and severe heart failure.
Topics: Aged; Calcium Channel Blockers; Coronary Disease; Heart Failure; Hemodynamics; Humans; Male; Mitral | 1985 |
Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure.
Topics: Administration, Oral; Adult; Age Factors; Aged; Blood Pressure; Cardiac Output; Heart Failure; Heart | 1985 |
Use of nifedipine in hypertrophic cardiomyopathy in infants. A report of two cases.
Topics: Cardiomyopathy, Hypertrophic; Echocardiography; Heart Failure; Humans; Infant, Newborn; Nifedipine | 1985 |
Effects of nifedipine on forearm vascular resistance and venous capacitance in normal subjects and in patients with congestive heart failure.
Topics: Adult; Cardiac Output; Female; Forearm; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nife | 1985 |
[Effect of verapamil and nifedipine on the fractional composition of calcium in the blood serum].
Topics: Calcium; Female; Heart Failure; Male; Nifedipine; Verapamil | 1985 |
Nifedipine in the management of hypertensive emergencies: report of two cases and review of the literature.
Topics: Administration, Oral; Aged; Blood Pressure; Cardiac Output; Cerebrovascular Disorders; Emergencies; | 1985 |
[Acute effect of nifedipine on pulmonary gas exchange in patients with severe cardiac insufficiency].
Topics: Adult; Aged; Cardiomyopathy, Dilated; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1985 |